Advanced Search (OLGA)

Gene: SLC23A2 (solute carrier family 23 member 2) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

SLC23A2

Name:

solute carrier family 23 member 2

RGD ID:

1353786

HGNC Page

HGNC:10973

Description:

Enables L-ascorbate:sodium symporter activity and L-ascorbic acid transmembrane transporter activity. Involved in L-ascorbic acid transmembrane transport. Located in apical plasma membrane and basolateral plasma membrane.

Type:

protein-coding

RefSeq Status:

REVIEWED

Previously known as:

hSVCT2; KIAA0238; Na(+)/L-ascorbic acid transporter 2; NBTL1; nucleobase transporter-like 1 protein; SLC23A1; sodium-dependent vitamin C transporter 2; sodium-dependent vitamin C transporter-2; solute carrier family 23 (ascorbic acid transporter), member 2; solute carrier family 23 (nucleobase transporters), member 1; solute carrier family 23 (nucleobase transporters), member 2; SVCT2; testicular secretory protein Li 48; yolk sac permease-like molecule 2; YSPL2

RGD Orthologs

Alliance Orthologs

More Info

more info ...

More Info

Species	Gene symbol and name	Data Source	Assertion derived from	less info ...
Orthologs ¹				less info ...
Mus musculus (house mouse):	Slc23a2 (solute carrier family 23 (nucleobase transporters), member 2)	HGNC	EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):	Slc23a2 (solute carrier family 23 member 2)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Chinchilla lanigera (long-tailed chinchilla):	Slc23a2 (solute carrier family 23 member 2)	NCBI	Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):	SLC23A2 (solute carrier family 23 member 2)	NCBI	Ortholog
Canis lupus familiaris (dog):	SLC23A2 (solute carrier family 23 member 2)	HGNC	EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, Treefam
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):	Slc23a2 (solute carrier family 23 member 2)	NCBI	Ortholog
Sus scrofa (pig):	SLC23A2 (solute carrier family 23 member 2)	HGNC	Ensembl, NCBI, OrthoDB
Chlorocebus sabaeus (green monkey):	SLC23A2 (solute carrier family 23 member 2)	NCBI	Ortholog
Heterocephalus glaber (naked mole-rat):	Slc23a2 (solute carrier family 23 member 2)	NCBI	Ortholog
Other homologs ²
Mus musculus (house mouse):	Slc23a1 (solute carrier family 23 (nucleobase transporters), member 1)	HGNC	OrthoDB, OrthoMCL
Rattus norvegicus (Norway rat):	Slc23a1 (solute carrier family 23 member 1)	HGNC	OrthoDB
Alliance orthologs ³
Rattus norvegicus (Norway rat):	Slc23a2 (solute carrier family 23 member 2)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Mus musculus (house mouse):	Slc23a2 (solute carrier family 23 (nucleobase transporters), member 2)	Alliance	DIOPT (Ensembl Compara\|HGNC\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Danio rerio (zebrafish):	slc23a2 (solute carrier family 23 member 2)	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid\|ZFIN)
Caenorhabditis elegans (roundworm):	C51E3.6	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Drosophila melanogaster (fruit fly):	CG6293	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoInspector\|PANTHER\|SonicParanoid)
Caenorhabditis elegans (roundworm):	R11E3.2	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoInspector\|PANTHER)
Caenorhabditis elegans (roundworm):	T07G12.2	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoInspector\|PANTHER)
Caenorhabditis elegans (roundworm):	T07G12.4	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Caenorhabditis elegans (roundworm):	T07G12.5	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Caenorhabditis elegans (roundworm):	Y59E9AL.4	Alliance	DIOPT (Ensembl Compara\|Hieranoid\|InParanoid\|OMA\|OrthoInspector\|PANTHER\|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):	slc23a2	Alliance	DIOPT (Hieranoid\|InParanoid\|OMA\|OrthoFinder\|OrthoInspector\|PANTHER\|PhylomeDB\|SonicParanoid)
Xenopus laevis (African clawed frog):	slc23a2.L	Alliance	DIOPT (Xenbase)
Xenopus laevis (African clawed frog):	slc23a2.S	Alliance	DIOPT (Xenbase)

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	20	4,852,358 - 5,010,313 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	20	4,852,356 - 5,010,293 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	20	4,833,004 - 4,990,959 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	20	4,781,002 - 4,938,939 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	20	4,781,001 - 4,938,939	NCBI
Celera	20	4,902,706 - 5,051,861 (-)	NCBI		Celera
Cytogenetic Map	20	p13	NCBI
HuRef	20	4,787,194 - 4,944,817 (-)	NCBI		HuRef
CHM1_1	20	4,834,496 - 4,992,439 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	20	4,891,820 - 5,049,741 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	Binge Drinking		ISO	RGD:619876	26884454		RGD

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	Huntington's disease-like 1		IAGP	RGD:156440945	8554872	ClinVar Annotator: match by term: Huntington disease-like 1	ClinVar	PMID:28492532
SLC23A2	Human	Inosine Triphosphatase Deficiency		IAGP	RGD:405874624	8554872	ClinVar Annotator: match by term: Inosine triphosphatase deficiency	ClinVar	PMID:26224535\|PMID:28492532\|PMID:34989426
SLC23A2	Human	pantothenate kinase-associated neurodegeneration		IAGP	RGD:156440945	8554872	ClinVar Annotator: match by term: Pigmentary pallidal degeneration	ClinVar	PMID:28492532

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	cholestasis		EXP		11554173	CTD Direct Evidence: marker/mechanism	CTD	PMID:18706437

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	1,2-dimethylhydrazine	decreases expression	ISO	RGD:733830	6480464	1,2-Dimethylhydrazine results in decreased expression of SLC23A2 mRNA	CTD	PMID:22206623
SLC23A2	Human	1,2-dimethylhydrazine	multiple interactions	ISO	RGD:733830	6480464	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC23A2 mRNA	CTD	PMID:22206623
SLC23A2	Human	17alpha-ethynylestradiol	increases expression	ISO	RGD:733830	6480464	Ethinyl Estradiol results in increased expression of SLC23A2 mRNA	CTD	PMID:17942748
SLC23A2	Human	17alpha-ethynylestradiol	multiple interactions	ISO	RGD:733830	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC23A2 mRNA	CTD	PMID:17942748
SLC23A2	Human	17beta-estradiol	multiple interactions	EXP		6480464	Estradiol inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]	CTD	PMID:17092984
SLC23A2	Human	17beta-estradiol	decreases expression	ISO	RGD:733830	6480464	Estradiol results in decreased expression of SLC23A2 mRNA	CTD	PMID:39298647
SLC23A2	Human	2,2',4,4'-Tetrabromodiphenyl ether	affects expression	ISO	RGD:733830	6480464	2,2',4,4'-tetrabromodiphenyl ether affects the expression of SLC23A2 mRNA	CTD	PMID:30294300
SLC23A2	Human	2,3,7,8-tetrachlorodibenzodioxine	multiple interactions	ISO	RGD:733830	6480464	[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC23A2 mRNA	CTD	PMID:17942748
SLC23A2	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:733830	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLC23A2 mRNA	CTD	PMID:33956508
SLC23A2	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:619876	6480464	Tetrachlorodibenzodioxin results in decreased expression of SLC23A2 mRNA	CTD	PMID:32109520\|PMID:34747641
SLC23A2	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		6480464	Tetrachlorodibenzodioxin results in decreased expression of SLC23A2 mRNA	CTD	PMID:27913140
SLC23A2	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	EXP		6480464	Tetrachlorodibenzodioxin results in increased expression of SLC23A2 mRNA	CTD	PMID:11489354\|PMID:19684285\|PMID:20106945\|PMID:21632981\|PMID:26238291
SLC23A2	Human	2-amino-2-deoxy-D-glucopyranose	increases expression	ISO	RGD:619876	6480464	Glucosamine results in increased expression of SLC23A2 mRNA	CTD	PMID:17109745
SLC23A2	Human	3-isobutyl-1-methyl-7H-xanthine	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
SLC23A2	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:733830	6480464	bisphenol S results in decreased expression of SLC23A2 mRNA	CTD	PMID:39298647
SLC23A2	Human	6-propyl-2-thiouracil	decreases expression	ISO	RGD:619876	6480464	Propylthiouracil results in decreased expression of SLC23A2 mRNA	CTD	PMID:24780913
SLC23A2	Human	aflatoxin B1	increases methylation	EXP		6480464	Aflatoxin B1 results in increased methylation of SLC23A2 intron	CTD	PMID:30157460
SLC23A2	Human	Aflatoxin B2 alpha	increases methylation	EXP		6480464	aflatoxin B2 results in increased methylation of SLC23A2 intron	CTD	PMID:30157460
SLC23A2	Human	aldehydo-D-glucosamine	increases expression	ISO	RGD:619876	6480464	Glucosamine results in increased expression of SLC23A2 mRNA	CTD	PMID:17109745
SLC23A2	Human	ammonium chloride	affects expression	ISO	RGD:619876	6480464	Ammonium Chloride affects the expression of SLC23A2 mRNA	CTD	PMID:16483693
SLC23A2	Human	antirheumatic drug	decreases expression	EXP		6480464	Antirheumatic Agents results in decreased expression of SLC23A2 mRNA	CTD	PMID:24449571
SLC23A2	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of SLC23A2 gene	CTD	PMID:25304211
SLC23A2	Human	arsane	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLC23A2	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of SLC23A2 gene	CTD	PMID:25304211
SLC23A2	Human	arsenic atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLC23A2	Human	arsenite(3-)	increases methylation	EXP		6480464	arsenite results in increased methylation of SLC23A2 promoter	CTD	PMID:23974009
SLC23A2	Human	arsenite(3-)	multiple interactions	EXP		6480464	arsenite inhibits the reaction [G3BP1 protein binds to SLC23A2 mRNA]	CTD	PMID:32406909
SLC23A2	Human	benzo[a]pyrene	increases expression	ISO	RGD:733830	6480464	Benzo(a)pyrene results in increased expression of SLC23A2 mRNA	CTD	PMID:22228805
SLC23A2	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of SLC23A2 5' UTR; Benzo(a)pyrene affects the methylation of SLC23A2 intron	CTD	PMID:27901495\|PMID:30157460
SLC23A2	Human	benzo[a]pyrene	decreases methylation	EXP		6480464	Benzo(a)pyrene results in decreased methylation of SLC23A2 promoter	CTD	PMID:27901495
SLC23A2	Human	benzo[a]pyrene	increases expression	EXP		6480464	Benzo(a)pyrene results in increased expression of SLC23A2 mRNA	CTD	PMID:21632981
SLC23A2	Human	beta-D-glucosamine	increases expression	ISO	RGD:619876	6480464	Glucosamine results in increased expression of SLC23A2 mRNA	CTD	PMID:17109745
SLC23A2	Human	bilirubin IXalpha	increases expression	EXP		6480464	Bilirubin results in increased expression of SLC23A2 mRNA	CTD	PMID:18706437
SLC23A2	Human	bisphenol A	increases expression	ISO	RGD:619876	6480464	bisphenol A results in increased expression of SLC23A2 mRNA	CTD	PMID:25181051\|PMID:30816183\|PMID:32528016
SLC23A2	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of SLC23A2 protein	CTD	PMID:32981897
SLC23A2	Human	bisphenol A	affects expression	EXP		6480464	bisphenol A affects the expression of SLC23A2 mRNA	CTD	PMID:30903817
SLC23A2	Human	bisphenol A	increases methylation	ISO	RGD:733830	6480464	bisphenol A results in increased methylation of SLC23A2 promoter	CTD	PMID:27312807
SLC23A2	Human	bisphenol F	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
SLC23A2	Human	butanal	decreases expression	EXP		6480464	butyraldehyde results in decreased expression of SLC23A2 mRNA	CTD	PMID:26079696
SLC23A2	Human	cadmium dichloride	decreases expression	EXP		6480464	Cadmium Chloride results in decreased expression of SLC23A2 mRNA	CTD	PMID:38568856
SLC23A2	Human	caffeine	increases phosphorylation	EXP		6480464	Caffeine results in increased phosphorylation of SLC23A2 protein	CTD	PMID:35688186
SLC23A2	Human	calcium atom	decreases expression	ISO	RGD:733830	6480464	Calcium deficiency results in decreased expression of SLC23A2 mRNA	CTD	PMID:12788230
SLC23A2	Human	calcium atom	multiple interactions	ISO	RGD:733830	6480464	Foscarnet inhibits the reaction [Calcium results in increased expression of SLC23A2 mRNA]; Nifedipine inhibits the more ...	CTD	PMID:12788230
SLC23A2	Human	calcium atom	increases expression	ISO	RGD:733830	6480464	Calcium results in increased expression of SLC23A2 mRNA; Calcium results in increased expression of SLC23A2 more ...	CTD	PMID:12788230
SLC23A2	Human	calcium(0)	decreases expression	ISO	RGD:733830	6480464	Calcium deficiency results in decreased expression of SLC23A2 mRNA	CTD	PMID:12788230
SLC23A2	Human	calcium(0)	multiple interactions	ISO	RGD:733830	6480464	Foscarnet inhibits the reaction [Calcium results in increased expression of SLC23A2 mRNA]; Nifedipine inhibits the more ...	CTD	PMID:12788230
SLC23A2	Human	calcium(0)	increases expression	ISO	RGD:733830	6480464	Calcium results in increased expression of SLC23A2 mRNA; Calcium results in increased expression of SLC23A2 more ...	CTD	PMID:12788230
SLC23A2	Human	carbamazepine	affects expression	EXP		6480464	Carbamazepine affects the expression of SLC23A2 mRNA	CTD	PMID:25979313
SLC23A2	Human	carbamazepine	increases expression	EXP		6480464	Carbamazepine results in increased expression of SLC23A2 mRNA	CTD	PMID:17112801
SLC23A2	Human	carbon nanotube	decreases expression	ISO	RGD:733830	6480464	Nanotubes, Carbon analog results in decreased expression of SLC23A2 mRNA; Nanotubes, Carbon results in decreased more ...	CTD	PMID:25554681\|PMID:25620056
SLC23A2	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to SLC23A2 gene]	CTD	PMID:28238834
SLC23A2	Human	chloroprene	increases expression	ISO	RGD:619876	6480464	Chloroprene results in increased expression of SLC23A2 mRNA	CTD	PMID:23125180
SLC23A2	Human	cisplatin	multiple interactions	EXP		6480464	[Cisplatin co-treated with jinfukang] results in increased expression of SLC23A2 mRNA	CTD	PMID:27392435
SLC23A2	Human	cobalt dichloride	decreases expression	EXP		6480464	cobaltous chloride results in decreased expression of SLC23A2 mRNA	CTD	PMID:19320972\|PMID:19376846
SLC23A2	Human	cortisol	multiple interactions	EXP		6480464	Hydrocortisone inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]	CTD	PMID:17092984
SLC23A2	Human	cyclosporin A	increases expression	EXP		6480464	Cyclosporine results in increased expression of SLC23A2 mRNA	CTD	PMID:25562108
SLC23A2	Human	cyproconazole	increases expression	ISO	RGD:733830	6480464	cyproconazole results in increased expression of SLC23A2 mRNA	CTD	PMID:22334560
SLC23A2	Human	dexamethasone	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:28628672
SLC23A2	Human	dichloroacetic acid	increases expression	ISO	RGD:733830	6480464	Dichloroacetic Acid results in increased expression of SLC23A2 mRNA	CTD	PMID:28962523
SLC23A2	Human	diclofenac	multiple interactions	EXP		6480464	Diclofenac inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]	CTD	PMID:17092984
SLC23A2	Human	dicrotophos	increases expression	EXP		6480464	dicrotophos results in increased expression of SLC23A2 mRNA	CTD	PMID:28302478
SLC23A2	Human	dioxygen	multiple interactions	ISO	RGD:619876	6480464	[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression more ...	CTD	PMID:33729688
SLC23A2	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
SLC23A2	Human	doxorubicin	decreases expression	EXP		6480464	Doxorubicin results in decreased expression of SLC23A2 mRNA	CTD	PMID:29803840
SLC23A2	Human	endosulfan	increases expression	ISO	RGD:619876	6480464	Endosulfan results in increased expression of SLC23A2 mRNA	CTD	PMID:29391264
SLC23A2	Human	epoxiconazole	increases expression	ISO	RGD:733830	6480464	epoxiconazole results in increased expression of SLC23A2 mRNA	CTD	PMID:22334560
SLC23A2	Human	ethanol	affects splicing	ISO	RGD:733830	6480464	Ethanol affects the splicing of SLC23A2 mRNA	CTD	PMID:30319688
SLC23A2	Human	flutamide	decreases expression	ISO	RGD:619876	6480464	Flutamide results in decreased expression of SLC23A2 mRNA	CTD	PMID:24793618
SLC23A2	Human	folic acid	multiple interactions	ISO	RGD:733830	6480464	[1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC23A2 mRNA	CTD	PMID:22206623
SLC23A2	Human	folic acid	decreases expression	ISO	RGD:733830	6480464	Folic Acid results in decreased expression of SLC23A2 mRNA	CTD	PMID:25629700
SLC23A2	Human	FR900359	increases phosphorylation	EXP		6480464	FR900359 results in increased phosphorylation of SLC23A2 protein	CTD	PMID:37730182
SLC23A2	Human	furan	decreases expression	ISO	RGD:733830	6480464	furan results in decreased expression of SLC23A2 mRNA	CTD	PMID:24183702
SLC23A2	Human	genistein	multiple interactions	EXP		6480464	Genistein inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]	CTD	PMID:17092984
SLC23A2	Human	gentamycin	increases expression	ISO	RGD:619876	6480464	Gentamicins results in increased expression of SLC23A2 mRNA	CTD	PMID:33387578
SLC23A2	Human	graphite	affects expression	ISO	RGD:619876	6480464	Graphite affects the expression of SLC23A2 mRNA	CTD	PMID:29933104
SLC23A2	Human	hexadecanoic acid	increases phosphorylation	EXP		6480464	Palmitic Acid results in increased phosphorylation of SLC23A2 protein	CTD	PMID:28073184
SLC23A2	Human	hypochlorous acid	increases expression	ISO	RGD:733830	6480464	Hypochlorous Acid results in increased expression of SLC23A2 mRNA	CTD	PMID:19376150
SLC23A2	Human	indometacin	multiple interactions	EXP		6480464	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ...	CTD	PMID:17092984\|PMID:28628672
SLC23A2	Human	iron atom	increases expression	ISO	RGD:619876	6480464	Iron deficiency results in increased expression of SLC23A2 mRNA	CTD	PMID:16629162
SLC23A2	Human	iron(0)	increases expression	ISO	RGD:619876	6480464	Iron deficiency results in increased expression of SLC23A2 mRNA	CTD	PMID:16629162
SLC23A2	Human	L-ascorbic acid	multiple interactions	EXP		6480464	Ascorbic Acid inhibits the reaction [nickel sulfate results in decreased expression of SLC23A2 mRNA]; Diclofenac more ...	CTD	PMID:16288478\|PMID:17092984
SLC23A2	Human	L-ascorbic acid	increases abundance	ISO	RGD:733830	6480464	SLC23A2 mRNA results in increased abundance of Ascorbic Acid	CTD	PMID:22558179
SLC23A2	Human	L-ascorbic acid	increases expression	ISO	RGD:733830	6480464	Ascorbic Acid deficiency results in increased expression of SLC23A2 protein; Ascorbic Acid results in increased more ...	CTD	PMID:20122894\|PMID:22001929
SLC23A2	Human	L-ascorbic acid	decreases expression	ISO	RGD:619876	6480464	Ascorbic Acid results in decreased expression of SLC23A2 mRNA	CTD	PMID:19418264
SLC23A2	Human	lead(0)	affects expression	EXP		6480464	Lead affects the expression of SLC23A2 mRNA	CTD	PMID:28903495
SLC23A2	Human	leflunomide	increases expression	EXP		6480464	leflunomide results in increased expression of SLC23A2 mRNA	CTD	PMID:28988120
SLC23A2	Human	levetiracetam	increases expression	ISO	RGD:619876	6480464	Levetiracetam results in increased expression of SLC23A2 mRNA	CTD	PMID:20345932
SLC23A2	Human	manganese atom	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLC23A2	Human	manganese(0)	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLC23A2	Human	manganese(II) chloride	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLC23A2	Human	morphine	decreases expression	ISO	RGD:619876	6480464	Morphine results in decreased expression of SLC23A2 mRNA	CTD	PMID:19418264
SLC23A2	Human	nickel sulfate	multiple interactions	EXP		6480464	Ascorbic Acid inhibits the reaction [nickel sulfate results in decreased expression of SLC23A2 mRNA]	CTD	PMID:16288478
SLC23A2	Human	nickel sulfate	decreases expression	EXP		6480464	nickel sulfate results in decreased expression of SLC23A2 mRNA	CTD	PMID:16288478\|PMID:22714537
SLC23A2	Human	nifedipine	multiple interactions	ISO	RGD:733830	6480464	Nifedipine inhibits the reaction [Calcium results in increased expression of SLC23A2 mRNA]; Nifedipine inhibits the more ...	CTD	PMID:12788230
SLC23A2	Human	ozone	multiple interactions	ISO	RGD:733830	6480464	GCLM gene mutant form promotes the reaction [Ozone results in increased expression of SLC23A2 mRNA]	CTD	PMID:20417186
SLC23A2	Human	paracetamol	affects expression	ISO	RGD:733830	6480464	Acetaminophen affects the expression of SLC23A2 mRNA	CTD	PMID:17562736
SLC23A2	Human	paracetamol	increases expression	ISO	RGD:619876	6480464	Acetaminophen results in increased expression of SLC23A2 mRNA	CTD	PMID:33387578
SLC23A2	Human	paracetamol	increases expression	EXP		6480464	Acetaminophen results in increased expression of SLC23A2 mRNA	CTD	PMID:22230336
SLC23A2	Human	paracetamol	decreases expression	EXP		6480464	Acetaminophen results in decreased expression of SLC23A2 mRNA	CTD	PMID:21420995
SLC23A2	Human	paraquat	decreases expression	ISO	RGD:733830	6480464	Paraquat results in decreased expression of SLC23A2 mRNA	CTD	PMID:22558179
SLC23A2	Human	phenobarbital	increases expression	ISO	RGD:733830	6480464	Phenobarbital results in increased expression of SLC23A2 mRNA	CTD	PMID:23091169
SLC23A2	Human	phosphonoformic acid	multiple interactions	ISO	RGD:733830	6480464	Foscarnet inhibits the reaction [Calcium results in increased expression of SLC23A2 mRNA]; Foscarnet inhibits the more ...	CTD	PMID:12788230
SLC23A2	Human	pirinixic acid	increases expression	ISO	RGD:733830	6480464	pirinixic acid results in increased expression of SLC23A2 mRNA	CTD	PMID:17426115\|PMID:18301758\|PMID:20813756\|PMID:23811191
SLC23A2	Human	progesterone	multiple interactions	EXP		6480464	Progesterone inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]	CTD	PMID:17092984
SLC23A2	Human	propiconazole	increases expression	ISO	RGD:733830	6480464	propiconazole results in increased expression of SLC23A2 mRNA	CTD	PMID:21278054\|PMID:22334560
SLC23A2	Human	quercetin	multiple interactions	EXP		6480464	Quercetin inhibits the reaction [SLC23A2 protein results in increased uptake of Ascorbic Acid]	CTD	PMID:17092984
SLC23A2	Human	rifampicin	increases expression	EXP		6480464	Rifampin results in increased expression of SLC23A2 mRNA	CTD	PMID:27199754
SLC23A2	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
SLC23A2	Human	silicon dioxide	decreases expression	EXP		6480464	Silicon Dioxide analog results in decreased expression of SLC23A2 mRNA	CTD	PMID:25895662
SLC23A2	Human	sodium arsenite	decreases expression	EXP		6480464	sodium arsenite results in decreased expression of SLC23A2 mRNA	CTD	PMID:38568856
SLC23A2	Human	sodium arsenite	multiple interactions	EXP		6480464	[[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ...	CTD	PMID:39836092
SLC23A2	Human	sodium dodecyl sulfate	increases expression	EXP		6480464	Sodium Dodecyl Sulfate results in increased expression of SLC23A2 mRNA	CTD	PMID:31734321
SLC23A2	Human	sunitinib	increases expression	EXP		6480464	Sunitinib results in increased expression of SLC23A2 mRNA	CTD	PMID:31533062
SLC23A2	Human	taurocholic acid	increases expression	EXP		6480464	Taurocholic Acid results in increased expression of SLC23A2 mRNA	CTD	PMID:18706437
SLC23A2	Human	tetrachloromethane	affects expression	ISO	RGD:733830	6480464	Carbon Tetrachloride affects the expression of SLC23A2 mRNA	CTD	PMID:17484886
SLC23A2	Human	thioacetamide	increases expression	ISO	RGD:619876	6480464	Thioacetamide results in increased expression of SLC23A2 mRNA	CTD	PMID:34492290
SLC23A2	Human	thiram	decreases expression	EXP		6480464	Thiram results in decreased expression of SLC23A2 mRNA	CTD	PMID:38568856
SLC23A2	Human	titanium dioxide	decreases expression	ISO	RGD:733830	6480464	titanium dioxide results in decreased expression of SLC23A2 mRNA	CTD	PMID:23557971
SLC23A2	Human	titanium dioxide	increases expression	ISO	RGD:733830	6480464	titanium dioxide results in increased expression of SLC23A2 mRNA	CTD	PMID:29264374\|PMID:35295148
SLC23A2	Human	toluene	affects expression	ISO	RGD:619876	6480464	Toluene affects the expression of SLC23A2 mRNA	CTD	PMID:18653662
SLC23A2	Human	trichloroethene	increases expression	ISO	RGD:733830	6480464	Trichloroethylene results in increased expression of SLC23A2 mRNA	CTD	PMID:25549359
SLC23A2	Human	trichloroethene	increases expression	ISO	RGD:619876	6480464	Trichloroethylene results in increased expression of SLC23A2 mRNA	CTD	PMID:33387578
SLC23A2	Human	trichostatin A	increases expression	EXP		6480464	trichostatin A results in increased expression of SLC23A2 mRNA	CTD	PMID:26272509
SLC23A2	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ...	CTD	PMID:27188386
SLC23A2	Human	troglitazone	decreases expression	ISO	RGD:733830	6480464	troglitazone results in decreased expression of SLC23A2 mRNA	CTD	PMID:28973697
SLC23A2	Human	tunicamycin	decreases expression	ISO	RGD:733830	6480464	Tunicamycin results in decreased expression of SLC23A2 mRNA	CTD	PMID:17127020
SLC23A2	Human	ursodeoxycholic acid	increases expression	EXP		6480464	Ursodeoxycholic Acid results in increased expression of SLC23A2 mRNA	CTD	PMID:18706437
SLC23A2	Human	valproic acid	decreases methylation	EXP		6480464	Valproic Acid results in decreased methylation of SLC23A2 gene	CTD	PMID:29154799
SLC23A2	Human	valproic acid	affects splicing	ISO	RGD:619876	6480464	Valproic Acid affects the splicing of SLC23A2 mRNA	CTD	PMID:29427782
SLC23A2	Human	valproic acid	increases expression	EXP		6480464	Valproic Acid results in increased expression of SLC23A2 mRNA	CTD	PMID:23179753\|PMID:24935251\|PMID:25192806\|PMID:27188386\|PMID:29154799
SLC23A2	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of SLC23A2 mRNA	CTD	PMID:25979313
SLC23A2	Human	zidovudine	increases expression	EXP		6480464	Zidovudine results in increased expression of SLC23A2 mRNA	CTD	PMID:24292225
SLC23A2	Human	zinc atom	multiple interactions	EXP		6480464	[PCI 5002 co-treated with Zinc] results in increased expression of SLC23A2 mRNA	CTD	PMID:18593933
SLC23A2	Human	zinc(0)	multiple interactions	EXP		6480464	[PCI 5002 co-treated with Zinc] results in increased expression of SLC23A2 mRNA	CTD	PMID:18593933
SLC23A2	Human	zoledronic acid	increases expression	EXP		6480464	zoledronic acid results in increased expression of SLC23A2 mRNA	CTD	PMID:20977926

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	blood circulation	acts_upstream_of_or_within	IEA	UniProtKB:Q9EPR4\|ensembl:ENSMUSP00000028815	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	cell adhesion	involved_in	IEA	UniProtKB-KW:KW-0130	150520179		UniProt	GO_REF:0000043
SLC23A2	Human	cellular response to ethanol		ISO	RGD:619876	9068941		RGD	PMID:27085842\|REF_RGD_ID:26884454
SLC23A2	Human	cellular response to ethanol	involved_in	IEA	UniProtKB:Q9WTW8\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	L-ascorbic acid metabolic process		ISO	RGD:619876	9068941		RGD	PMID:10331392\|REF_RGD_ID:634186
SLC23A2	Human	L-ascorbic acid metabolic process	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-196836
SLC23A2	Human	L-ascorbic acid metabolic process	involved_in	NAS		150520179	PMID:10556521	UniProt	PMID:10556521
SLC23A2	Human	L-ascorbic acid metabolic process	involved_in	IEA	UniProtKB:Q9WTW8\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	L-ascorbic acid transmembrane transport		ISO	RGD:619876	9068941		RGD	PMID:10331392\|REF_RGD_ID:634186
SLC23A2	Human	L-ascorbic acid transmembrane transport	involved_in	IEA	UniProtKB:Q9EPR4\|UniProtKB:Q9WTW8\|ensembl:ENSMUSP00000028815\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	L-ascorbic acid transmembrane transport	involved_in	IBA	MGI:1859682\|PANTHER:PTN002595872\|RGD:619876\|UniProtKB:B9VMA9\|UniProtKB:Q9UGH3	150520179		GO_Central	GO_REF:0000033
SLC23A2	Human	L-ascorbic acid transmembrane transport	involved_in	IDA		150520179	PMID:10471399, PMID:10631088, PMID:18247577, PMID:18417304, PMID:19216494	UniProt	PMID:10471399\|PMID:10631088\|PMID:18247577\|PMID:18417304\|PMID:19216494
SLC23A2	Human	monoatomic ion transport	involved_in	IEA	UniProtKB-KW:KW-0406	150520179		UniProt	GO_REF:0000043
SLC23A2	Human	negative regulation of cellular process		ISO	RGD:619876	9068941	cortical neuron death	RGD	PMID:27085842\|REF_RGD_ID:26884454
SLC23A2	Human	positive regulation of dendrite extension		ISO	RGD:619876	9068941		RGD	PMID:27085842\|REF_RGD_ID:26884454
SLC23A2	Human	positive regulation of dendrite extension	involved_in	IEA	UniProtKB:Q9WTW8\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	response to oxidative stress		ISO	RGD:619876	9068941		RGD	PMID:12887688\|REF_RGD_ID:1580612
SLC23A2	Human	response to oxidative stress	involved_in	IEA	UniProtKB:Q9WTW8\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	sodium ion transport	involved_in	IEA	UniProtKB-KW:KW-0739	150520179		UniProt	GO_REF:0000043
SLC23A2	Human	transmembrane transport	involved_in	IEA	InterPro:IPR006042\|InterPro:IPR006043	150520179		InterPro	GO_REF:0000002

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	apical plasma membrane	is_active_in	IBA	PANTHER:PTN002595872\|UniProtKB:B9VMA9\|UniProtKB:Q9UGH3	150520179		GO_Central	GO_REF:0000033
SLC23A2	Human	apical plasma membrane	located_in	IDA		150520179	PMID:18417304	UniProt	PMID:18417304
SLC23A2	Human	basal plasma membrane	located_in	IEA	UniProtKB:Q9EPR4\|UniProtKB:Q9WTW8\|ensembl:ENSMUSP00000028815\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	basolateral plasma membrane	located_in	IDA		150520179	PMID:15993839, PMID:18247577, PMID:18417304, PMID:19216494	UniProt	PMID:15993839\|PMID:18247577\|PMID:18417304\|PMID:19216494
SLC23A2	Human	cytoplasm	located_in	IEA	UniProtKB:Q9EPR4\|UniProtKB:Q9WTW8\|ensembl:ENSMUSP00000028815\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	membrane	located_in	IEA	UniProtKB-KW:KW-0472	150520179		UniProt	GO_REF:0000043
SLC23A2	Human	membrane	located_in	IEA	UniProtKB-SubCell:SL-0162	150520179		UniProt	GO_REF:0000044
SLC23A2	Human	membrane	located_in	IC	GO:0008520	150520179	PMID:10471399	UniProt	PMID:10471399
SLC23A2	Human	membrane	located_in	IEA	InterPro:IPR006042\|InterPro:IPR006043	150520179		InterPro	GO_REF:0000002
SLC23A2	Human	plasma membrane	located_in	IEA	UniProtKB-KW:KW-1003	150520179		UniProt	GO_REF:0000043
SLC23A2	Human	plasma membrane	located_in	IEA	ARBA:ARBA00027801	150520179		UniProt	GO_REF:0000117
SLC23A2	Human	plasma membrane	located_in	IDA		150520179	PMID:10631088	UniProt	PMID:10631088
SLC23A2	Human	plasma membrane	located_in	TAS		150520179		Reactome	Reactome:R-HSA-198870
SLC23A2	Human	plasma membrane	located_in	IEA	UniProtKB-SubCell:SL-0039	150520179		UniProt	GO_REF:0000044

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
SLC23A2	Human	L-ascorbate:sodium symporter activity		ISO	RGD:619876	9068941		RGD	PMID:10331392\|REF_RGD_ID:634186
SLC23A2	Human	L-ascorbate:sodium symporter activity	enables	IEA	UniProtKB:Q9EPR4\|UniProtKB:Q9WTW8\|ensembl:ENSMUSP00000028815\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	L-ascorbate:sodium symporter activity	enables	IBA	MGI:1859682\|PANTHER:PTN002595872\|RGD:619876\|UniProtKB:B9VMA9\|UniProtKB:Q9UGH3	150520179		GO_Central	GO_REF:0000033
SLC23A2	Human	L-ascorbate:sodium symporter activity	enables	IDA		150520179	PMID:10471399, PMID:10631088, PMID:15993839	UniProt	PMID:10471399\|PMID:10631088\|PMID:15993839
SLC23A2	Human	L-ascorbic acid transmembrane transporter activity	enables	TAS		150520179		Reactome	Reactome:R-HSA-198870
SLC23A2	Human	L-ascorbic acid transmembrane transporter activity	enables	IEA	UniProtKB:Q9EPR4\|UniProtKB:Q9WTW8\|ensembl:ENSMUSP00000028815\|ensembl:ENSRNOP00000098618	150520179		Ensembl	GO_REF:0000107
SLC23A2	Human	L-ascorbic acid transmembrane transporter activity	enables	IBA	MGI:1859682\|PANTHER:PTN002595872\|RGD:619876\|UniProtKB:Q9UGH3	150520179		GO_Central	GO_REF:0000033
SLC23A2	Human	L-ascorbic acid transmembrane transporter activity	enables	IDA		150520179	PMID:10471399, PMID:10631088, PMID:18247577, PMID:18417304, PMID:19216494	UniProt	PMID:10471399\|PMID:10631088\|PMID:18247577\|PMID:18417304\|PMID:19216494
SLC23A2	Human	protein binding	enables	IPI	UniProtKB:Q9BQT9-1	150520179	PMID:34673103	UniProt	PMID:34673103
SLC23A2	Human	symporter activity	enables	IEA	UniProtKB-KW:KW-0769	150520179		UniProt	GO_REF:0000043
SLC23A2	Human	transmembrane transporter activity	enables	IEA	InterPro:IPR006042\|InterPro:IPR006043	150520179		InterPro	GO_REF:0000002
SLC23A2	Human	transmembrane transporter activity	enables	IEA	ARBA:ARBA00028127	150520179		UniProt	GO_REF:0000117

#	Reference Title	Reference Citation
1.	Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery.	Erichsen HC, etal., Am J Epidemiol. 2006 Feb 1;163(3):245-54. Epub 2005 Dec 15.
2.	GOAs Human GO annotations	GOA_HUMAN data from the GO Consortium
3.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions
4.	SVCT2, a potential therapeutic target, protects against oxidative stress during ethanol-induced neurotoxicity via JNK/p38 MAPKs, NF-κB and miRNA125a-5p.	Tian H, etal., Free Radic Biol Med. 2016 Jul;96:362-73. doi: 10.1016/j.freeradbiomed.2016.03.039. Epub 2016 Apr 13.
5.	A family of mammalian Na+-dependent L-ascorbic acid transporters.	Tsukaguchi H, etal., Nature 1999 May 6;399(6731):70-5.

PMID:9039502	PMID:9804989	PMID:10395795	PMID:10471399	PMID:10556521	PMID:10631088	PMID:10748165	PMID:10915794	PMID:11396616	PMID:11780052	PMID:11984580	PMID:12168954
PMID:12477932	PMID:14993613	PMID:15060139	PMID:15340249	PMID:15489334	PMID:15921655	PMID:15993839	PMID:16380174	PMID:17012227	PMID:17092984	PMID:17291984	PMID:17664139
PMID:18247577	PMID:18417304	PMID:18614995	PMID:18619416	PMID:18636124	PMID:18676680	PMID:18791929	PMID:18845575	PMID:19162177	PMID:19170196	PMID:19216494	PMID:19232538
PMID:19243932	PMID:19346260	PMID:19625176	PMID:19692168	PMID:19926816	PMID:19953087	PMID:20379614	PMID:20453000	PMID:20471816	PMID:20588054	PMID:21335086	PMID:21733302
PMID:21770893	PMID:21873635	PMID:21988832	PMID:22171153	PMID:22348976	PMID:22990596	PMID:23288661	PMID:23401652	PMID:23613229	PMID:23837633	PMID:23990905	PMID:23999113
PMID:24401033	PMID:24594434	PMID:24815519	PMID:25102111	PMID:25242204	PMID:25645015	PMID:25821969	PMID:26186194	PMID:26188149	PMID:26646539	PMID:26838684	PMID:27012422
PMID:27932501	PMID:28385602	PMID:29507755	PMID:29545069	PMID:30021884	PMID:30194290	PMID:30902760	PMID:32296183	PMID:32319585	PMID:33484802	PMID:33580460	PMID:33845483
PMID:33961781	PMID:34186245	PMID:34599650	PMID:34673103	PMID:34780525	PMID:35271311	PMID:35337019	PMID:35417255	PMID:36310070	PMID:36436457	PMID:37390985	PMID:37423323
PMID:38117590	PMID:38182073

SLC23A2
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	20	4,852,358 - 5,010,313 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	20	4,852,356 - 5,010,293 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	20	4,833,004 - 4,990,959 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	20	4,781,002 - 4,938,939 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	20	4,781,001 - 4,938,939	NCBI
Celera	20	4,902,706 - 5,051,861 (-)	NCBI		Celera
Cytogenetic Map	20	p13	NCBI
HuRef	20	4,787,194 - 4,944,817 (-)	NCBI		HuRef
CHM1_1	20	4,834,496 - 4,992,439 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	20	4,891,820 - 5,049,741 (-)	NCBI		T2T-CHM13v2.0

Slc23a2
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	2	131,894,416 - 131,987,287 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	2	131,894,416 - 131,987,028 (-)	Ensembl		GRCm39 Ensembl
GRCm38	2	132,052,496 - 132,145,320 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	2	132,052,496 - 132,145,108 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	2	131,878,232 - 131,970,844 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	2	131,743,937 - 131,836,549 (-)	NCBI		MGSCv36	mm8
Celera	2	133,279,011 - 133,328,217 (-)	NCBI		Celera
Cytogenetic Map	2	F2	NCBI
cM Map	2	64.15	NCBI

Slc23a2
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	3	139,755,583 - 139,913,304 (-)	NCBI		GRCr8
mRatBN7.2	3	119,302,651 - 119,395,289 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	3	119,302,666 - 119,460,343 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	3	123,206,656 - 123,298,423 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	3	131,793,663 - 131,885,649 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	3	129,462,752 - 129,554,530 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	3	124,632,491 - 124,842,225 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	3	124,632,492 - 124,724,252 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	3	131,132,124 - 131,266,028 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	3	119,796,376 - 119,886,011 (-)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	3	119,701,948 - 119,791,584 (-)	NCBI
Celera	3	118,102,047 - 118,150,099 (-)	NCBI		Celera
Cytogenetic Map	3	q36	NCBI

Slc23a2
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955415	15,565,249 - 15,642,153 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955415	15,565,344 - 15,677,935 (-)	NCBI	ChiLan1.0	ChiLan1.0

SLC23A2
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	21	5,801,682 - 6,017,566 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	20	5,798,507 - 6,014,383 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	20	4,874,185 - 5,024,750 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	20	4,670,294 - 4,790,800 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	20	4,670,294 - 4,790,800 (-)	Ensembl	panpan1.1		panPan2

SLC23A2
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	24	16,573,616 - 16,709,296 (+)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	24	16,574,168 - 16,709,296 (+)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	24	16,425,818 - 16,531,856 (+)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	24	16,981,643 - 17,127,359 (+)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	24	16,990,701 - 17,127,359 (+)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	24	16,613,514 - 16,719,979 (+)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	24	16,720,357 - 16,826,526 (+)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	24	17,054,182 - 17,160,266 (+)	NCBI		UU_Cfam_GSD_1.0

Slc23a2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024408640	165,431,608 - 165,545,259 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936485	13,885,091 - 13,976,550 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936485	13,885,067 - 13,976,623 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

SLC23A2
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	17	13,848,728 - 14,011,700 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	17	13,848,726 - 14,012,054 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	17	14,819,223 - 14,825,302 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

SLC23A2
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	2	33,092,619 - 33,209,258 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	2	33,128,061 - 33,212,255 (+)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666071	11,323,229 - 11,470,263 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Slc23a2
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624741	5,917,019 - 6,000,720 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624741	5,917,620 - 6,050,922 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in SLC23A2
43 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 20p13-11.21(chr20:89939-25697564)x3	copy number gain	See cases [RCV000051227]	Chr20:89939..25697564 [GRCh38] Chr20:70580..25678200 [GRCh37] Chr20:18580..25626200 [NCBI36] Chr20:20p13-11.21	pathogenic
GRCh38/hg38 20p13-11.23(chr20:89939-19146279)x3	copy number gain	See cases [RCV000051041]	Chr20:89939..19146279 [GRCh38] Chr20:70580..19126923 [GRCh37] Chr20:18580..19074923 [NCBI36] Chr20:20p13-11.23	pathogenic
GRCh38/hg38 20p13-11.23(chr20:89939-19071495)x3	copy number gain	See cases [RCV000052995]	Chr20:89939..19071495 [GRCh38] Chr20:70580..19052139 [GRCh37] Chr20:18580..19000139 [NCBI36] Chr20:20p13-11.23	pathogenic
GRCh38/hg38 20p13-11.22(chr20:89939-21787252)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052996]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052996]\|See cases [RCV000052996]	Chr20:89939..21787252 [GRCh38] Chr20:70580..21767890 [GRCh37] Chr20:18580..21715890 [NCBI36] Chr20:20p13-11.22	pathogenic
GRCh38/hg38 20p13-12.1(chr20:89939-14818511)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052997]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052997]\|See cases [RCV000052997]	Chr20:89939..14818511 [GRCh38] Chr20:70580..14799157 [GRCh37] Chr20:18580..14747157 [NCBI36] Chr20:20p13-12.1	pathogenic
GRCh38/hg38 20p13-q11.1(chr20:80106-30227427)x3	copy number gain	See cases [RCV000133996]	Chr20:80106..30227427 [GRCh38] Chr20:60747..29462103 [GRCh37] Chr20:8747..28075764 [NCBI36] Chr20:20p13-q11.1	pathogenic
GRCh38/hg38 20p13-q13.33(chr20:99557-64277321)x3	copy number gain	See cases [RCV000135859]	Chr20:99557..64277321 [GRCh38] Chr20:80198..62908674 [GRCh37] Chr20:28198..62379118 [NCBI36] Chr20:20p13-q13.33	pathogenic
GRCh38/hg38 20p13(chr20:4594991-5050271)x3	copy number gain	See cases [RCV000135607]	Chr20:4594991..5050271 [GRCh38] Chr20:4575637..5030917 [GRCh37] Chr20:4523637..4978917 [NCBI36] Chr20:20p13	uncertain significance
GRCh38/hg38 20p13-12.3(chr20:4343033-6911730)x1	copy number loss	See cases [RCV000137695]	Chr20:4343033..6911730 [GRCh38] Chr20:4323680..6892377 [GRCh37] Chr20:4271680..6840377 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh38/hg38 20p13-12.1(chr20:80106-13029401)x3	copy number gain	See cases [RCV000138677]	Chr20:80106..13029401 [GRCh38] Chr20:60747..13010049 [GRCh37] Chr20:8747..12958049 [NCBI36] Chr20:20p13-12.1	pathogenic
GRCh38/hg38 20p13-12.3(chr20:84402-6159078)x3	copy number gain	See cases [RCV000141348]	Chr20:84402..6159078 [GRCh38] Chr20:65043..6139725 [GRCh37] Chr20:13043..6087725 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh38/hg38 20p13-11.1(chr20:80927-26324843)x3	copy number gain	See cases [RCV000142017]	Chr20:80927..26324843 [GRCh38] Chr20:61568..26305479 [GRCh37] Chr20:9568..26253479 [NCBI36] Chr20:20p13-11.1	pathogenic
GRCh38/hg38 20p13-12.3(chr20:80927-5447679)x3	copy number gain	See cases [RCV000142285]	Chr20:80927..5447679 [GRCh38] Chr20:61568..5428325 [GRCh37] Chr20:9568..5376325 [NCBI36] Chr20:20p13-12.3	uncertain significance
GRCh38/hg38 20p13-12.3(chr20:1269303-8626911)x3	copy number gain	See cases [RCV000142917]	Chr20:1269303..8626911 [GRCh38] Chr20:1249947..8607558 [GRCh37] Chr20:1197947..8555558 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh37/hg19 20p13-12.3(chr20:121521-5564937)x3	copy number gain	See cases [RCV000239772]	Chr20:121521..5564937 [GRCh37] Chr20:20p13-12.3	pathogenic
GRCh37/hg19 20p13-11.1(chr20:80198-26075841)x3	copy number gain	See cases [RCV000239954]	Chr20:80198..26075841 [GRCh37] Chr20:20p13-11.1	pathogenic
GRCh37/hg19 20p13(chr20:61568-4914872)x3	copy number gain	See cases [RCV000446883]	Chr20:61568..4914872 [GRCh37] Chr20:20p13	pathogenic
GRCh37/hg19 20p13-12.1(chr20:4392930-12667768)x1	copy number loss	See cases [RCV000446718]	Chr20:4392930..12667768 [GRCh37] Chr20:20p13-12.1	pathogenic
GRCh37/hg19 20p13(chr20:4931970-4972088)	copy number loss	Abnormal esophagus morphology [RCV000416906]	Chr20:4931970..4972088 [GRCh37] Chr20:20p13	likely benign
GRCh38/hg38 20p13-12.3(chr20:80093-6386012)x3	copy number gain	See cases [RCV000139597]	Chr20:80093..6386012 [GRCh38] Chr20:60734..6366659 [GRCh37] Chr20:8734..6314659 [NCBI36] Chr20:20p13-12.3	pathogenic
GRCh38/hg38 20p13-12.3(chr20:4926195-5543771)x3	copy number gain	See cases [RCV000139625]	Chr20:4926195..5543771 [GRCh38] Chr20:4906841..5524417 [GRCh37] Chr20:4854841..5472417 [NCBI36] Chr20:20p13-12.3	uncertain significance
GRCh38/hg38 20p13-11.23(chr20:80928-18688031)x3	copy number gain	See cases [RCV000143426]	Chr20:80928..18688031 [GRCh38] Chr20:61569..18668675 [GRCh37] Chr20:9569..18616675 [NCBI36] Chr20:20p13-11.23	pathogenic
GRCh37/hg19 20p13(chr20:61568-4904599)x3	copy number gain	See cases [RCV000448397]	Chr20:61568..4904599 [GRCh37] Chr20:20p13	pathogenic
GRCh37/hg19 20p13-12.3(chr20:213423-5483406)x3	copy number gain	See cases [RCV000510531]	Chr20:213423..5483406 [GRCh37] Chr20:20p13-12.3	uncertain significance
GRCh37/hg19 20p13-12.3(chr20:2463101-8185680)x1	copy number loss	See cases [RCV000511897]	Chr20:2463101..8185680 [GRCh37] Chr20:20p13-12.3	pathogenic
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)x3	copy number gain	See cases [RCV000510832]	Chr20:61569..62915555 [GRCh37] Chr20:20p13-q13.33	pathogenic
NM_005116.6(SLC23A2):c.1946C>T (p.Thr649Met)	single nucleotide variant	not specified [RCV004297181]	Chr20:4856979 [GRCh38] Chr20:4837625 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.137G>A (p.Ser46Asn)	single nucleotide variant	not specified [RCV004306627]	Chr20:4912950 [GRCh38] Chr20:4893596 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-q13.33(chr20:61569-62915555)	copy number gain	See cases [RCV000512450]	Chr20:61569..62915555 [GRCh37] Chr20:20p13-q13.33	pathogenic
GRCh37/hg19 20p13-12.2(chr20:61568-10486106)x3	copy number gain	See cases [RCV000512556]	Chr20:61568..10486106 [GRCh37] Chr20:20p13-12.2	likely pathogenic
GRCh37/hg19 20p13-12.1(chr20:3092739-17091453)x1	copy number loss	not provided [RCV000684134]	Chr20:3092739..17091453 [GRCh37] Chr20:20p13-12.1	pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62948788)x3	copy number gain	not provided [RCV000741058]	Chr20:63244..62948788 [GRCh37] Chr20:20p13-q13.33	pathogenic
GRCh37/hg19 20p13-q13.33(chr20:63244-62961294)x3	copy number gain	not provided [RCV000741059]	Chr20:63244..62961294 [GRCh37] Chr20:20p13-q13.33	pathogenic
GRCh37/hg19 20p13(chr20:4822040-4855759)x3	copy number gain	not provided [RCV000741079]	Chr20:4822040..4855759 [GRCh37] Chr20:20p13	benign
GRCh37/hg19 20p13-q13.33(chr20:63244-62912463)x3	copy number gain	not provided [RCV000741057]	Chr20:63244..62912463 [GRCh37] Chr20:20p13-q13.33	pathogenic
NM_005116.6(SLC23A2):c.1158C>T (p.Ala386=)	single nucleotide variant	not provided [RCV000967547]	Chr20:4869998 [GRCh38] Chr20:4850644 [GRCh37] Chr20:20p13	benign
NM_005116.6(SLC23A2):c.1233C>A (p.Pro411=)	single nucleotide variant	not provided [RCV000927027]	Chr20:4869923 [GRCh38] Chr20:4850569 [GRCh37] Chr20:20p13	likely benign
NM_005116.6(SLC23A2):c.139G>A (p.Gly47Ser)	single nucleotide variant	not provided [RCV000902073]	Chr20:4912948 [GRCh38] Chr20:4893594 [GRCh37] Chr20:20p13	likely benign
NM_005116.6(SLC23A2):c.914C>T (p.Ala305Val)	single nucleotide variant	not specified [RCV004313730]	Chr20:4874607 [GRCh38] Chr20:4855253 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.482+10G>A	single nucleotide variant	not provided [RCV000974401]	Chr20:4899545 [GRCh38] Chr20:4880191 [GRCh37] Chr20:20p13	benign
NM_005116.6(SLC23A2):c.1080G>T (p.Pro360=)	single nucleotide variant	not provided [RCV000961675]	Chr20:4873958 [GRCh38] Chr20:4854604 [GRCh37] Chr20:20p13	benign
NM_005116.6(SLC23A2):c.858C>T (p.Tyr286=)	single nucleotide variant	not provided [RCV000957747]	Chr20:4874663 [GRCh38] Chr20:4855309 [GRCh37] Chr20:20p13	benign
NM_005116.6(SLC23A2):c.786G>A (p.Ala262=)	single nucleotide variant	not provided [RCV000911106]	Chr20:4883680 [GRCh38] Chr20:4864326 [GRCh37] Chr20:20p13	benign
GRCh37/hg19 20p13-11.1(chr20:61568-26305479)x3	copy number gain	not provided [RCV001007068]	Chr20:61568..26305479 [GRCh37] Chr20:20p13-11.1	pathogenic
GRCh37/hg19 20p13-12.2(chr20:3178539-11848383)	copy number loss	20p12.3 microdeletion syndrome [RCV002280726]	Chr20:3178539..11848383 [GRCh37] Chr20:20p13-12.2	pathogenic
GRCh37/hg19 20p13(chr20:3092739-4939933)x3	copy number gain	not provided [RCV001258903]	Chr20:3092739..4939933 [GRCh37] Chr20:20p13	uncertain significance
NC_000020.10:g.(?_1959939)_(6760201_?)dup	duplication	Huntington disease-like 1 [RCV003110989]\|Pigmentary pallidal degeneration [RCV003122285]	Chr20:1959939..6760201 [GRCh37] Chr20:20p13-12.3	uncertain significance
NM_005116.6(SLC23A2):c.212C>T (p.Ser71Phe)	single nucleotide variant	not specified [RCV004202721]	Chr20:4902554 [GRCh38] Chr20:4883200 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.193G>A (p.Gly65Ser)	single nucleotide variant	not specified [RCV004238276]	Chr20:4912894 [GRCh38] Chr20:4893540 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.257G>A (p.Arg86Gln)	single nucleotide variant	not specified [RCV004083139]	Chr20:4902509 [GRCh38] Chr20:4883155 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.125G>T (p.Gly42Val)	single nucleotide variant	not specified [RCV004150899]	Chr20:4912962 [GRCh38] Chr20:4893608 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.814A>G (p.Ile272Val)	single nucleotide variant	not specified [RCV004208038]	Chr20:4883652 [GRCh38] Chr20:4864298 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.127G>T (p.Ala43Ser)	single nucleotide variant	not specified [RCV004167748]	Chr20:4912960 [GRCh38] Chr20:4893606 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.245T>C (p.Leu82Pro)	single nucleotide variant	not specified [RCV004141024]	Chr20:4902521 [GRCh38] Chr20:4883167 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.277A>G (p.Ile93Val)	single nucleotide variant	not specified [RCV004076976]	Chr20:4902489 [GRCh38] Chr20:4883135 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-12.3(chr20:3034557-5524417)x1	copy number loss	See cases [RCV003158005]	Chr20:3034557..5524417 [GRCh37] Chr20:20p13-12.3	likely pathogenic
GRCh38/hg38 20p13-11.21(chr20:87153-23635465)x3	copy number gain	Renal agenesis [RCV003327640]	Chr20:87153..23635465 [GRCh38] Chr20:20p13-11.21	pathogenic
NM_005116.6(SLC23A2):c.638G>A (p.Arg213Gln)	single nucleotide variant	not specified [RCV004337287]	Chr20:4884757 [GRCh38] Chr20:4865403 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-12.2(chr20:61569-9542361)x3	copy number gain	not provided [RCV003485207]	Chr20:61569..9542361 [GRCh37] Chr20:20p13-12.2	pathogenic
GRCh37/hg19 20p13-11.21(chr20:68351-23860313)x3	copy number gain	not provided [RCV003885495]	Chr20:68351..23860313 [GRCh37] Chr20:20p13-11.21	pathogenic
GRCh37/hg19 20p13-12.1(chr20:68351-16142323)x3	copy number gain	not provided [RCV003885494]	Chr20:68351..16142323 [GRCh37] Chr20:20p13-12.1	pathogenic
NM_005116.6(SLC23A2):c.562A>G (p.Asn188Asp)	single nucleotide variant	not specified [RCV004451373]	Chr20:4885830 [GRCh38] Chr20:4866476 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1744C>T (p.Arg582Trp)	single nucleotide variant	not specified [RCV004451368]	Chr20:4857181 [GRCh38] Chr20:4837827 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.185C>T (p.Thr62Met)	single nucleotide variant	not specified [RCV004451371]	Chr20:4912902 [GRCh38] Chr20:4893548 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1799C>T (p.Ser600Leu)	single nucleotide variant	not specified [RCV004451370]	Chr20:4857126 [GRCh38] Chr20:4837772 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1754A>G (p.Lys585Arg)	single nucleotide variant	not specified [RCV004451369]	Chr20:4857171 [GRCh38] Chr20:4837817 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.182C>G (p.Thr61Ser)	single nucleotide variant	not specified [RCV004676599]	Chr20:4912905 [GRCh38] Chr20:4893551 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1786G>A (p.Asp596Asn)	single nucleotide variant	not specified [RCV004672269]	Chr20:4857139 [GRCh38] Chr20:4837785 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1163T>A (p.Val388Asp)	single nucleotide variant	not specified [RCV004672270]	Chr20:4869993 [GRCh38] Chr20:4850639 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1909G>A (p.Asp637Asn)	single nucleotide variant	not specified [RCV004859762]	Chr20:4857016 [GRCh38] Chr20:4837662 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.619A>C (p.Ile207Leu)	single nucleotide variant	not specified [RCV004859763]	Chr20:4884776 [GRCh38] Chr20:4865422 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1240G>A (p.Ala414Thr)	single nucleotide variant	not specified [RCV004859765]	Chr20:4869916 [GRCh38] Chr20:4850562 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1857A>C (p.Leu619Phe)	single nucleotide variant	not specified [RCV004859766]	Chr20:4857068 [GRCh38] Chr20:4837714 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.509T>C (p.Phe170Ser)	single nucleotide variant	not specified [RCV004859764]	Chr20:4885883 [GRCh38] Chr20:4866529 [GRCh37] Chr20:20p13	uncertain significance
GRCh37/hg19 20p13-q11.21(chr20:80198-26208081)x3	copy number gain	not provided [RCV000487461]	Chr20:80198..26208081 [GRCh37] Chr20:20p13-q11.21	pathogenic
NM_005116.6(SLC23A2):c.174G>A (p.Ala58=)	single nucleotide variant	not provided [RCV000974454]	Chr20:4912913 [GRCh38] Chr20:4893559 [GRCh37] Chr20:20p13	benign
NM_005116.6(SLC23A2):c.619A>T (p.Ile207Phe)	single nucleotide variant	not specified [RCV004141333]	Chr20:4884776 [GRCh38] Chr20:4865422 [GRCh37] Chr20:20p13	uncertain significance
NM_005116.6(SLC23A2):c.1297G>T (p.Gly433Cys)	single nucleotide variant	not specified [RCV004346742]	Chr20:4867829 [GRCh38] Chr20:4848475 [GRCh37] Chr20:20p13	uncertain significance
NC_000020.10:g.(?_3190198)_(6760201_?)del	deletion	Inosine triphosphatase deficiency [RCV004579445]	Chr20:3190198..6760201 [GRCh37] Chr20:20p13-12.3	pathogenic
NM_005116.6(SLC23A2):c.37A>G (p.Met13Val)	single nucleotide variant	not specified [RCV004859761]	Chr20:4932526 [GRCh38] Chr20:4913172 [GRCh37] Chr20:20p13	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	4589
Count of miRNA genes:	1127
Interacting mature miRNAs:	1405
Transcripts:	ENST00000338244, ENST00000379333, ENST00000423430, ENST00000424750, ENST00000468355, ENST00000496331
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
407405512	GWAS1054488_H	obsolete_red blood cell distribution width QTL GWAS1054488 (human)		1e-12	obsolete_red blood cell distribution width		20	5002446	5002447	Human
597598239	GWAS1655099_H	mean corpuscular hemoglobin concentration QTL GWAS1655099 (human)		3e-24	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	20	4997142	4997143	Human
597584730	GWAS1641590_H	mean corpuscular hemoglobin concentration QTL GWAS1641590 (human)		2e-11	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	20	5000094	5000095	Human
597335057	GWAS1431131_H	severe acute respiratory syndrome, COVID-19 QTL GWAS1431131 (human)		5e-11	severe acute respiratory syndrome, COVID-19		20	4999240	4999241	Human
597614290	GWAS1671150_H	sodium measurement QTL GWAS1671150 (human)		1e-19	sodium measurement	blood sodium level (CMO:0000499)	20	4863241	4863242	Human
407090126	GWAS739102_H	obsolete_red blood cell distribution width QTL GWAS739102 (human)		4e-15	obsolete_red blood cell distribution width		20	5001959	5001960	Human
597614225	GWAS1671085_H	sodium measurement QTL GWAS1671085 (human)		3e-11	sodium measurement	blood sodium level (CMO:0000499)	20	4856675	4856676	Human
597599565	GWAS1656425_H	mean corpuscular hemoglobin concentration QTL GWAS1656425 (human)		2e-23	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	20	4997142	4997143	Human
597344782	GWAS1440856_H	neutrophil measurement QTL GWAS1440856 (human)		1e-16	neutrophil measurement		20	4961828	4961829	Human
597046529	GWAS1142603_H	Red cell distribution width QTL GWAS1142603 (human)		3e-11	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	20	4999759	4999760	Human
597045070	GWAS1141144_H	mean corpuscular hemoglobin QTL GWAS1141144 (human)		2e-18	mean corpuscular volume	mean corpuscular hemoglobin (CMO:0000290)	20	5002446	5002447	Human
406991003	GWAS639979_H	mean corpuscular hemoglobin concentration QTL GWAS639979 (human)		3e-19	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	20	5002446	5002447	Human
596954382	GWAS1073901_H	Red cell distribution width QTL GWAS1073901 (human)		3e-11	Red cell distribution width		20	4999759	4999760	Human
597584133	GWAS1640993_H	mean corpuscular hemoglobin concentration QTL GWAS1640993 (human)		2e-12	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	20	4993955	4993956	Human
597278020	GWAS1374094_H	aging QTL GWAS1374094 (human)		0.000009	aging		20	4961115	4961116	Human
407382229	GWAS1031205_H	obsolete_red blood cell distribution width QTL GWAS1031205 (human)		3e-11	obsolete_red blood cell distribution width		20	4999759	4999760	Human
597602112	GWAS1658972_H	chloride measurement QTL GWAS1658972 (human)		2e-14	chloride measurement	blood chloride level (CMO:0000497)	20	4856675	4856676	Human
596953675	GWAS1073194_H	Red cell distribution width QTL GWAS1073194 (human)		2e-11	Red cell distribution width		20	5001472	5001473	Human
597614074	GWAS1670934_H	sodium measurement QTL GWAS1670934 (human)		7e-18	sodium measurement	blood sodium level (CMO:0000499)	20	4856675	4856676	Human
597583481	GWAS1640341_H	mean corpuscular hemoglobin concentration QTL GWAS1640341 (human)		3e-12	mean corpuscular hemoglobin concentration	mean corpuscular hemoglobin concentration (CMO:0000291)	20	4997142	4997143	Human
407384545	GWAS1033521_H	obsolete_red blood cell distribution width QTL GWAS1033521 (human)		2e-11	obsolete_red blood cell distribution width		20	5001472	5001473	Human
597086332	GWAS1182406_H	mean corpuscular hemoglobin QTL GWAS1182406 (human)		1e-17	mean corpuscular hemoglobin	mean corpuscular hemoglobin (CMO:0000290)	20	5002446	5002447	Human
597602098	GWAS1658958_H	chloride measurement QTL GWAS1658958 (human)		7e-13	chloride measurement	blood chloride level (CMO:0000497)	20	4856675	4856676	Human
597079611	GWAS1175685_H	Red cell distribution width QTL GWAS1175685 (human)		1e-12	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	20	5002446	5002447	Human
596950821	GWAS1070340_H	Red cell distribution width QTL GWAS1070340 (human)		1e-12	Red cell distribution width		20	5002446	5002447	Human
597111973	GWAS1208047_H	Red cell distribution width QTL GWAS1208047 (human)		4e-15	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	20	5001959	5001960	Human
597595501	GWAS1652361_H	chloride measurement QTL GWAS1652361 (human)		8e-14	chloride measurement	blood chloride level (CMO:0000497)	20	4856675	4856676	Human
596975782	GWAS1095301_H	Red cell distribution width QTL GWAS1095301 (human)		4e-15	Red cell distribution width		20	5001959	5001960	Human
597080034	GWAS1176108_H	Red cell distribution width QTL GWAS1176108 (human)		2e-11	Red cell distribution width	red blood cell distribution width- standard deviation (CMO:0003232)	20	5001472	5001473	Human
597607204	GWAS1664064_H	sodium measurement QTL GWAS1664064 (human)		9e-23	sodium measurement	blood sodium level (CMO:0000499)	20	4856675	4856676	Human
597607138	GWAS1663998_H	sodium measurement QTL GWAS1663998 (human)		2e-11	sodium measurement	blood sodium level (CMO:0000499)	20	4856675	4856676	Human

Z94337

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,932,865 - 4,932,984	UniSTS	GRCh37
Build 36	20	4,880,865 - 4,880,984	RGD	NCBI36
Celera	20	5,002,559 - 5,002,678	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,886,798 - 4,886,917	UniSTS

T03153

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,833,305 - 4,833,515	UniSTS	GRCh37
Build 36	20	4,781,305 - 4,781,515	RGD	NCBI36
Celera	20	4,903,009 - 4,903,219	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,787,497 - 4,787,707	UniSTS
Whitehead-YAC Contig Map	20		UniSTS

RH118444

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,879,596 - 4,879,910	UniSTS	GRCh37
Build 36	20	4,827,596 - 4,827,910	RGD	NCBI36
Celera	20	4,949,307 - 4,949,621	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,833,792 - 4,834,106	UniSTS
TNG Radiation Hybrid Map	20	3069.0	UniSTS

SHGC-110394

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,849,158 - 4,849,454	UniSTS	GRCh37
Build 36	20	4,797,158 - 4,797,454	RGD	NCBI36
Celera	20	4,918,863 - 4,919,159	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,803,343 - 4,803,639	UniSTS
TNG Radiation Hybrid Map	20	3094.0	UniSTS

SHGC-147858

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,907,209 - 4,907,509	UniSTS	GRCh37
Build 36	20	4,855,209 - 4,855,509	RGD	NCBI36
Celera	20	4,976,903 - 4,977,203	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,861,141 - 4,861,441	UniSTS
TNG Radiation Hybrid Map	20	3041.0	UniSTS

SHGC-149645

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,854,349 - 4,854,660	UniSTS	GRCh37
Build 36	20	4,802,349 - 4,802,660	RGD	NCBI36
Celera	20	4,924,054 - 4,924,365	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,808,533 - 4,808,844	UniSTS
TNG Radiation Hybrid Map	20	3082.0	UniSTS

SLC23A2_2187

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,835,693 - 4,836,505	UniSTS	GRCh37
Build 36	20	4,783,693 - 4,784,505	RGD	NCBI36
Celera	20	4,905,397 - 4,906,209	RGD
HuRef	20	4,789,885 - 4,790,697	UniSTS

Z94315

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,894,033 - 4,894,153	UniSTS	GRCh37
Build 36	20	4,842,033 - 4,842,153	RGD	NCBI36
Celera	20	4,963,727 - 4,963,847	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,847,964 - 4,848,084	UniSTS

RH47957

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	20	4,907,217 - 4,907,371	UniSTS	GRCh37
Build 36	20	4,855,217 - 4,855,371	RGD	NCBI36
Celera	20	4,976,911 - 4,977,065	RGD
Cytogenetic Map	20	p13	UniSTS
HuRef	20	4,861,149 - 4,861,303	UniSTS
GeneMap99-GB4 RH Map	20	28.85	UniSTS
NCBI RH Map	20	40.4	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2437	2788	2250	4972	1726	2351	6	623	1951	465	2269	7299	6468	53	3734	1	852	1743	1616	174	1


RefSeq Transcripts	NG_029959	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_005116	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_203327	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AB075494	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF058319	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF092511	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AF164142	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AI742576	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AJ269478	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AJ292318	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK025668	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK296304	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK297253	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL109841	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL121890	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL389886	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AY380556	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC013112	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC073895	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471133	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068258	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	D87075	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DQ011866	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	EF032501	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	HM005588	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000338244 ⟹ ENSP00000344322

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	4,852,358 - 5,001,510 (-)	Ensembl

Ensembl Acc Id:

ENST00000379333 ⟹ ENSP00000368637

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	4,852,356 - 5,010,293 (-)	Ensembl

Ensembl Acc Id:

ENST00000423430 ⟹ ENSP00000396364

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	4,859,367 - 4,899,647 (-)	Ensembl

Ensembl Acc Id:

ENST00000468355

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	4,869,588 - 5,010,270 (-)	Ensembl

Ensembl Acc Id:

ENST00000496331

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	20	4,873,877 - 4,885,991 (-)	Ensembl

RefSeq Acc Id:

NM_005116 ⟹ NP_005107

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	4,852,358 - 5,001,510 (-)	NCBI
GRCh37	20	4,833,002 - 4,990,939 (-)	NCBI
Build 36	20	4,781,002 - 4,930,145 (-)	NCBI Archive
HuRef	20	4,787,194 - 4,944,817 (-)	NCBI
CHM1_1	20	4,834,496 - 4,983,645 (-)	NCBI
T2T-CHM13v2.0	20	4,891,820 - 5,040,932 (-)	NCBI

Sequence:

show sequence

GCCATTTTGCAGGCGGCTGTCGCGGGGACCGGAGGCGGAGGCTGCAGCGGGCACTGCGGCGCCGAGGCGCGGCGGCAGGACGGGAACCACGCGAGCTGCAGCCAGCTAGGTCTTGACTCCACTAACGG
GGACTTCTCATACGGCTTTGAACTTGGACCTTGGTGCATAAGCAAATGTAACTCAGCGAATTGTAATGGAAAGCATATGGACAGGTCTACGCCACATCACTTAGGTGCTAAGAGATGCCGTTTGCAGG
CCTCATCTCTGCTTGAGAATCGGGGGCTCCAGGCACTAGAAGAGCCGGCTGATCCTGGGCTCCTAGCTTGAATAAGCCTTCACTTCCAGCTGCTCTCCCCAACGGCTGTGTAAACTACTCGTTTCTCT
TAATGATGGGTATTGGTAAGAATACCACATCCAAATCAATGGAGGCTGGAAGTTCAACAGAAGGCAAATACGAAGACGAGGCAAAGCACCCAGCTTTCTTCACTCTTCCGGTGGTGATAAATGGAGGC
GCCACCTCCAGCGGTGAGCAGGACAATGAGGACACTGAGCTCATGGCGATCTACACTACGGAAAACGGCATTGCAGAAAAGAGCTCTCTCGCTGAGACCCTGGATAGCACTGGCAGTCTGGACCCCCA
GCGATCAGACATGATTTATACCATAGAAGATGTTCCTCCCTGGTACCTGTGTATATTTCTGGGGCTACAGCACTACCTGACATGCTTCAGCGGCACGATCGCAGTGCCCTTCCTGTTGGCCGATGCCA
TGTGTGTGGGGTACGACCAGTGGGCCACCAGCCAGCTCATTGGGACCATTTTCTTCTGTGTGGGAATCACTACTTTGCTACAGACAACGTTTGGATGCAGGTTACCCCTGTTTCAGGCCAGTGCTTTT
GCATTTTTGGCCCCTGCTCGAGCCATCCTGTCTTTAGATAAATGGAAATGTAACACCACAGATGTTTCAGTTGCCAATGGAACAGCAGAGCTGTTGCACACAGAACACATCTGGTATCCCCGGATCCG
AGAGATCCAGGGGGCCATCATCATGTCCTCACTGATAGAAGTAGTCATCGGCCTCCTCGGCCTGCCTGGGGCTCTACTGAAGTACATCGGTCCCTTGACCATTACACCCACGGTGGCCCTAATTGGCC
TCTCTGGTTTCCAGGCAGCGGGGGAGAGAGCCGGGAAGCACTGGGGCATTGCCATGCTGACAATATTCCTAGTATTACTGTTTTCTCAATACGCCAGAAATGTTAAATTTCCTCTCCCGATTTATAAA
TCCAAGAAAGGATGGACTGCGTACAAGTTACAGCTGTTCAAAATGTTCCCTATCATCCTGGCCATCCTGGTATCCTGGCTGCTCTGCTTCATCTTCACGGTGACAGATGTCTTCCCTCCCGACAGCAC
AAAGTATGGCTTCTATGCTCGCACAGATGCCAGGCAAGGCGTGCTTCTGGTAGCCCCGTGGTTTAAGGTTCCATACCCATTTCAGTGGGGACTGCCCACCGTGTCTGCGGCCGGTGTCATCGGCATGC
TCAGTGCCGTGGTCGCCAGCATCATCGAGTCTATTGGTGACTACTACGCCTGTGCACGGCTGTCCTGTGCCCCACCCCCCCCCATCCACGCAATAAACAGGGGAATTTTCGTGGAAGGCCTCTCCTGT
GTTCTTGATGGCATATTTGGTACTGGGAATGGCTCTACTTCATCCAGTCCCAACATTGGAGTTTTGGGAATTACAAAGGTCGGCAGCCGCCGCGTGATACAGTGCGGAGCAGCCCTCATGCTCGCTCT
GGGCATGATCGGGAAGTTCAGCGCCCTCTTTGCGTCCCTTCCGGATCCTGTGCTGGGAGCCCTGTTCTGCACGCTCTTTGGAATGATCACAGCTGTTGGCCTCTCTAACCTGCAGTTCATTGATTTAA
ATTCTTCCCGGAACCTCTTTGTGCTTGGATTTTCGATCTTCTTTGGGCTCGTCCTTCCAAGTTACCTCAGACAGAACCCTCTGGTCACAGGGATAACAGGAATCGATCAAGTGTTGAACGTCCTTCTC
ACAACTGCTATGTTTGTAGGGGGCTGTGTGGCTTTTATCCTGGATAACACCATCCCAGGCACTCCAGAGGAAAGAGGAATCCGGAAATGGAAGAAGGGTGTGGGCAAAGGGAACAAATCACTCGACGG
CATGGAGTCGTACAATTTGCCATTTGGCATGAACATTATAAAAAAATACAGATGCTTCAGCTACTTACCCATCAGCCCAACCTTTGTGGGCTACACATGGAAAGGCCTCAGGAAGAGCGACAACAGCC
GGAGTTCAGATGAAGACTCCCAGGCCACGGGATAGCCTTTGCTGTGCCCTGTGGCCTGGCCGCAGTGAGGCATGTATCTGTAGTTCCTTGCTGAGTAACAAGAAGTAAAATACATGTTTGTATATCTA
CATTTACATTCTGCGCCCCAGAGCTAAGACAGACTGCGAATCACTTTTCTGCTGTGAGGGTGATGGTGCCTGATGCGGTGTCTCGCCTATCTCCTTATTTAAGCCCTTAACTCCTTGCCCTTTGAGAG
TGTCCATTGCTGGCCATGGTCACTAAATTTGAAGTTCCAGTCCTCCCTTTGGAGTGGACATTTAAAATCTGCAGCCATTCCTTGCTTCAGTTCCCTTCCACCACCCAGGGCTGGCTTTCCTATAAGCC
ACCTCCAGGGTCCAGGGGCTTTCTCTCTCTCTCCGAAGCCCCTGGACCTGTTTCCTTGTCATTTGACCCTCGTCTGTGCCCGCGGAGACCTCCTCTGACCAAGGGGCACTAGTATGCCTTGCGCTATC
ATGACTGACTGGCCCAGTATGATTCTGTTGTCGCTGATCTCCCGGAGGAGGAGGCTGTTGACCTGAAAACAGTGGCGTGGCTCCCCTGTGCCCAGATCTGGCCATGGGTGAGGCCTGCACAGATGTTG
AATGAACATCTGTTTGGGGCATTGGAGGGAAAAGGAAAGGACCCTGAAGCCAATATCTGATTCTCGGCTGCACCTTCTCTTGGCCACCCTGGCCCTGACCGGGCCAGCACGTGCACACTGGCCTCTTT
TCATTTCACTAGTGGCCGAGACACCCTCTCTGGCATTTATCACTGTTGGCCGGTGTGATGAGTATAGAGTGCCACCCAAGGCACCAGTCACACAAGCTGATGGGCGTCTTGGCTCTGCCGTCATGTGG
ATGTTATTGTCGCGCGCGTCTATAATTACAAGGTTTTATTCCTATTTAATGTTATTGACTATAGCAGATTTTGGAAATCAGTGTTTTCCATGTGACCCTCTTTCCTTGCATCCCTATTCCTTGTCCCC
CACCCACTCTTCCCCCCATCAAGAAAAGAACCAGCATTTGTAAAGCTGTGGACACCATCAGGGAAGCTTGTTGTAACGGCTTTTGAAGGCCAGTAACCATTGTTGTGGTTGTGTTTTGTATTGCTTGA
TACCATGAAAGTGTAAATACTGTAATGCCTAATCTATTTATCAAAACTGACTACTGGACCGGAGCCCAGAAACCATGGGTCAAGTTACACGTGAATTTGTTTTGTGAAGAAGGGAAGCTGGGGCAGGT
AACACGCAGAGCCGCCACGTGGAACGGTCTGTCCGCCGGTCTGTCCCGCTTGCCGGGCTTCTGTTGCAAGTCTTGGCTTAAGGAGACTTCCTGTGGGTTGCCATGTCGCACGTCCGTTAGATCTTGAT
TTTACAGGTGAGGGTGGTTGCCAAAGGTGATAAGAAAAGCAGCCAACAGGCTCCCTCTCACTTAAGAGAGTTCTAATTAATAACACTAAATTCTTCCTGAGAAATGACTCCTCTTGGTTTGGTTTGAA
GTTTTTCAGTGAAGGAAAAGGCCTGAGATAGGAAGCAGTGCCCTCGCTTCATGAGGTGGCACATCTTCGGTGGCCGTTGGCCTGGTCGAGCTTTGGTCAGCTGCGTGGGTGCCTGTCTCCTGTCTCCA
GCGGCAGGGCATGGTTCTTGGCAGCCTGGTGTCCACACGGTGCATTCCTGTCCCCCTCGGCCCCAGGCTGGCTCAGCTCTCCAGTGCTGCGGCGCTGTCTTTGCAGCATTGCCATGTCACCGTAGCCC
CCTTCACTCTTGGAAGTTTGGGGCTTCAAGGTTTATTCTGGCAAGAACACCTCGGAGCCACTGCATTGTTTTGCCAAAAACTTACTGCAGATTAAGTAAAGAACTTAGATGCTAAATTACATCTAATT
TTGTATGTTTTTTTAAATGTGTCTTTGATGCATACTTTAGAAGCACACTGGCTCGCGGTTTCCATCCCTCTTGCCTTGGGACACTCTTGAGGCTGGCAGCCCTCCTGCAATGAGTTGCTCTCAGTTCC
TTCTGTTTGGATTTTGCTCAACATCTCCAGTTTCTCTGCTCTGAAAAATGGGGAAAACTGCTAAACATCCCAGAGATTTGCAATCTTCTAGCTCTCCAGGTGAGCAGAAAGACCAAATATCCAAATAA
AAGCCTGAAAGCCATTGGTGATCCAGGGGCACCTTCTCTTCAGCTTGACTGGGCGTCTTCCGCTGCATAACACTCAAGGTGTCTGCTCTAGTCATCCAGAAACCCACTCCCTTCTGAAGCCCCTCCTT
GGGCCGGGTTGTATCAGGAGGATTCAACCCCGCTAACATGTGGGGTGCCCTCTGTAGGCCTTCACACAGGGAAGGAAGCCCTACCCTTTCAACTCCTGTTGGAGTGAGAGTTTCCTGTTCTGATTCCA
CTGTGGCCAACCCAATAATTCTGTCCGAGGAGGGGTAAGGGAATAGGAGGTGGGGAGCAAAGAGGGCAGCCTGACTAGATGCCCCTGCTGAATCTGGTACTTTCTGCACAGCCTTGAGTGATTGGAGT
CCCCTAATGACTAATAAACTTGAACATGTAACACACACACACACACACACACACACCATTTTAGGAAGTGGTTCTCCTACTGGAAAATATGCTACAGAATGAAAGTTTGTAATTGAAAGAAAAAGAAT
GTATTCATCTGCTTCTTGGGTTTAAGCACACACCTGAAGGGGAGATATTGGGGGACACGGTGGCCACTCGCGGTCTGTGTCATGACACTTCCCATTCACATCATTGGCCTGCGTTGCTGGGGCTTTGA
ACCACCACCCCGTACTTTGTTTTGCCTGTAGAGTGTTGTAAAATATTTTGGATGTGAATGTCCTTGCAGGCCGGTTAGTCTCCAGTTTCCACAGAGACCACCTACCCACCACCTTCCCAGGTCACCTG
CCTGGTCCCTGAAAGAAAGCATTTGTGTGGGCAATCCCAACATGAAATGTAGACAGCGTGAATACGGACAGGAGGTGATGCCATATTCACAGTGGGGGATGGAGGGCCCCCACCCCTGCTTCACAGAA
TAATGGGAAGTGACTCTAGTCTTTGTAAGCAATTTTCATTCTCATTAGGAAGTTAAATGTAGATTCACAGATACATTTACTTTCAGAATCCTCAAGAGGATTTCAAATGCTAACTTTTAGTTTCTTGG
GATTGATCAAGGCAAGAGAAGTGGCTTTAACCATGCCAGCCAGAATGAAGCATCATGGGTCCTGATGGTTTCCCGTTTTCATGGTAACAAATTCGCACAGAGGTTTTGCTTTATGCTGTAGAATACCG
ACTTTCATGATGACAACTTGGTTTATGCATGAATATTGCAGTATTTCCATATAGCAAAATAACATTTCTACCCAGGATAATAGTCACAGTTTTCCAGGGAGGGAATGATATAATTTTCATGACAATGT
CATGTGATGATAGAATTTCTCCATTGATGAATCTCTAGTATGTGTGTATACTTTATTTACCCATACGTATATTTTATGACCATGAGCTAAGTTGTTATTTCTTTCATTCATATCCCTGCTGAAATATT
GGTACTAGCAACTTAAAGTTGGCAAGTCTCATCTTCAGTAATACGGATGCCATGGGAGTGGCCAGGCCAGATTGAAGGTGAATATGGAGCAGTAGCAGAAGCCTCATTCCAGAACCCATCTGGCCAGA
GAAGCAGCAGCATCCTGGGGGATGGCCGTGCATGGGGTGTACACTCGCTATAGGCATAGGCCCGGCATGGCTGTCGCTGGACGCCAGCTGTGCACACCCAGCCACACCTGCTGCACGCCGCGTTAGTG
TGCGGCTCCGGGCCTGAGCATTCGCAAAGCTCGCTTCTCCAGGGAGCCTCCTCTTGGCTTTGGAAAAGAGCCCAGGGACTTAACGTGCTGCCTGTTGTACTCTGTCCCCTCATGACTTTTTAGACACA
GGGACTAGGACATCGACCACCCTCTGCCCCTCCTGCAGTCAGAACCCGAGTAGTGCAAGAACGGCCACCCGGTTTTGCCAGCGTTCAGCGTCTGCCCATGGACCCATAAGGCACATTAGCGTTGGGGG
TCTCTTTTCAGCAGCCTCACAGACATTCCCGTCCTTTCTGGTTGGTGTTGACTGTGTTTCAGCATCACTCTACCCTCCCATGTCCTTAGCATTGCTGTGCGTGTTTCCAGGCACTTAGGACACCCTTC
CCCACGTTGCCATCTTACTGACAGTTCAAATGACTCTCCTTTTTTGTTCGTTAGTAACAATCTTCATTTGACACCTTAATACATTTCTGACTGTTCTTAAAACAGTGGGGATGCCTATATTTTCCTTG
AGTTTTTGTGACTGACTTTGGCTATATATACCTTTCTGGGGTTTTGTTTGTTTTTTATTTTTATTTTGATTACCGAGGGTATTTGGGGTGGGGTTGTTTTTTGAGATGTGTAATTCTTTTATGGAGTT
TTTAAAAAGAATTTTCATATTGTTTTTCTAACATGGCTTCATTAAACGTTTAAGTATTTTAAAAATATGTAATATTTGGACCAGATGTTGTGAATAATAGTAGAGATAAAGCTATTTTATTCTGTATT
TTTAAAACTGTTCCGTACAAATAAAAGCTCTCCTGGACACA

hide sequence

RefSeq Acc Id:

NM_203327 ⟹ NP_976072

RefSeq Status:

REVIEWED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	4,852,358 - 5,010,313 (-)	NCBI
GRCh37	20	4,833,002 - 4,990,939 (-)	NCBI
Build 36	20	4,781,002 - 4,938,939 (-)	NCBI Archive
HuRef	20	4,787,194 - 4,944,817 (-)	NCBI
CHM1_1	20	4,834,496 - 4,992,439 (-)	NCBI
T2T-CHM13v2.0	20	4,891,820 - 5,049,741 (-)	NCBI

Sequence:

show sequence

ACCCTCTTCTGGAGCAGGGCCATTCATCTTCTCCTGCCCTTGGACATCACAGCTCCAGGAACTC
AGATCTTCAGACTCAGGGTGAAGGACACCACCAGCTTTCCAGGTTCCCCAGCTTGCAGACGGCATACGCTAGGTCTTGACTCCACTAACGGGGACTTCTCATACGGCTTTGAACTTGGACCTTGGTGC
ATAAGCAAATGTAACTCAGCGAATTGTAATGGAAAGCATATGGACAGGTCTACGCCACATCACTTAGGTGCTAAGAGATGCCGTTTGCAGGCCTCATCTCTGCTTGAGAATCGGGGGCTCCAGGCACT
AGAAGAGCCGGCTGATCCTGGGCTCCTAGCTTGAATAAGCCTTCACTTCCAGCTGCTCTCCCCAACGGCTGTGTAAACTACTCGTTTCTCTTAATGATGGGTATTGGTAAGAATACCACATCCAAATC
AATGGAGGCTGGAAGTTCAACAGAAGGCAAATACGAAGACGAGGCAAAGCACCCAGCTTTCTTCACTCTTCCGGTGGTGATAAATGGAGGCGCCACCTCCAGCGGTGAGCAGGACAATGAGGACACTG
AGCTCATGGCGATCTACACTACGGAAAACGGCATTGCAGAAAAGAGCTCTCTCGCTGAGACCCTGGATAGCACTGGCAGTCTGGACCCCCAGCGATCAGACATGATTTATACCATAGAAGATGTTCCT
CCCTGGTACCTGTGTATATTTCTGGGGCTACAGCACTACCTGACATGCTTCAGCGGCACGATCGCAGTGCCCTTCCTGTTGGCCGATGCCATGTGTGTGGGGTACGACCAGTGGGCCACCAGCCAGCT
CATTGGGACCATTTTCTTCTGTGTGGGAATCACTACTTTGCTACAGACAACGTTTGGATGCAGGTTACCCCTGTTTCAGGCCAGTGCTTTTGCATTTTTGGCCCCTGCTCGAGCCATCCTGTCTTTAG
ATAAATGGAAATGTAACACCACAGATGTTTCAGTTGCCAATGGAACAGCAGAGCTGTTGCACACAGAACACATCTGGTATCCCCGGATCCGAGAGATCCAGGGGGCCATCATCATGTCCTCACTGATA
GAAGTAGTCATCGGCCTCCTCGGCCTGCCTGGGGCTCTACTGAAGTACATCGGTCCCTTGACCATTACACCCACGGTGGCCCTAATTGGCCTCTCTGGTTTCCAGGCAGCGGGGGAGAGAGCCGGGAA
GCACTGGGGCATTGCCATGCTGACAATATTCCTAGTATTACTGTTTTCTCAATACGCCAGAAATGTTAAATTTCCTCTCCCGATTTATAAATCCAAGAAAGGATGGACTGCGTACAAGTTACAGCTGT
TCAAAATGTTCCCTATCATCCTGGCCATCCTGGTATCCTGGCTGCTCTGCTTCATCTTCACGGTGACAGATGTCTTCCCTCCCGACAGCACAAAGTATGGCTTCTATGCTCGCACAGATGCCAGGCAA
GGCGTGCTTCTGGTAGCCCCGTGGTTTAAGGTTCCATACCCATTTCAGTGGGGACTGCCCACCGTGTCTGCGGCCGGTGTCATCGGCATGCTCAGTGCCGTGGTCGCCAGCATCATCGAGTCTATTGG
TGACTACTACGCCTGTGCACGGCTGTCCTGTGCCCCACCCCCCCCCATCCACGCAATAAACAGGGGAATTTTCGTGGAAGGCCTCTCCTGTGTTCTTGATGGCATATTTGGTACTGGGAATGGCTCTA
CTTCATCCAGTCCCAACATTGGAGTTTTGGGAATTACAAAGGTCGGCAGCCGCCGCGTGATACAGTGCGGAGCAGCCCTCATGCTCGCTCTGGGCATGATCGGGAAGTTCAGCGCCCTCTTTGCGTCC
CTTCCGGATCCTGTGCTGGGAGCCCTGTTCTGCACGCTCTTTGGAATGATCACAGCTGTTGGCCTCTCTAACCTGCAGTTCATTGATTTAAATTCTTCCCGGAACCTCTTTGTGCTTGGATTTTCGAT
CTTCTTTGGGCTCGTCCTTCCAAGTTACCTCAGACAGAACCCTCTGGTCACAGGGATAACAGGAATCGATCAAGTGTTGAACGTCCTTCTCACAACTGCTATGTTTGTAGGGGGCTGTGTGGCTTTTA
TCCTGGATAACACCATCCCAGGCACTCCAGAGGAAAGAGGAATCCGGAAATGGAAGAAGGGTGTGGGCAAAGGGAACAAATCACTCGACGGCATGGAGTCGTACAATTTGCCATTTGGCATGAACATT
ATAAAAAAATACAGATGCTTCAGCTACTTACCCATCAGCCCAACCTTTGTGGGCTACACATGGAAAGGCCTCAGGAAGAGCGACAACAGCCGGAGTTCAGATGAAGACTCCCAGGCCACGGGATAGCC
TTTGCTGTGCCCTGTGGCCTGGCCGCAGTGAGGCATGTATCTGTAGTTCCTTGCTGAGTAACAAGAAGTAAAATACATGTTTGTATATCTACATTTACATTCTGCGCCCCAGAGCTAAGACAGACTGC
GAATCACTTTTCTGCTGTGAGGGTGATGGTGCCTGATGCGGTGTCTCGCCTATCTCCTTATTTAAGCCCTTAACTCCTTGCCCTTTGAGAGTGTCCATTGCTGGCCATGGTCACTAAATTTGAAGTTC
CAGTCCTCCCTTTGGAGTGGACATTTAAAATCTGCAGCCATTCCTTGCTTCAGTTCCCTTCCACCACCCAGGGCTGGCTTTCCTATAAGCCACCTCCAGGGTCCAGGGGCTTTCTCTCTCTCTCCGAA
GCCCCTGGACCTGTTTCCTTGTCATTTGACCCTCGTCTGTGCCCGCGGAGACCTCCTCTGACCAAGGGGCACTAGTATGCCTTGCGCTATCATGACTGACTGGCCCAGTATGATTCTGTTGTCGCTGA
TCTCCCGGAGGAGGAGGCTGTTGACCTGAAAACAGTGGCGTGGCTCCCCTGTGCCCAGATCTGGCCATGGGTGAGGCCTGCACAGATGTTGAATGAACATCTGTTTGGGGCATTGGAGGGAAAAGGAA
AGGACCCTGAAGCCAATATCTGATTCTCGGCTGCACCTTCTCTTGGCCACCCTGGCCCTGACCGGGCCAGCACGTGCACACTGGCCTCTTTTCATTTCACTAGTGGCCGAGACACCCTCTCTGGCATT
TATCACTGTTGGCCGGTGTGATGAGTATAGAGTGCCACCCAAGGCACCAGTCACACAAGCTGATGGGCGTCTTGGCTCTGCCGTCATGTGGATGTTATTGTCGCGCGCGTCTATAATTACAAGGTTTT
ATTCCTATTTAATGTTATTGACTATAGCAGATTTTGGAAATCAGTGTTTTCCATGTGACCCTCTTTCCTTGCATCCCTATTCCTTGTCCCCCACCCACTCTTCCCCCCATCAAGAAAAGAACCAGCAT
TTGTAAAGCTGTGGACACCATCAGGGAAGCTTGTTGTAACGGCTTTTGAAGGCCAGTAACCATTGTTGTGGTTGTGTTTTGTATTGCTTGATACCATGAAAGTGTAAATACTGTAATGCCTAATCTAT
TTATCAAAACTGACTACTGGACCGGAGCCCAGAAACCATGGGTCAAGTTACACGTGAATTTGTTTTGTGAAGAAGGGAAGCTGGGGCAGGTAACACGCAGAGCCGCCACGTGGAACGGTCTGTCCGCC
GGTCTGTCCCGCTTGCCGGGCTTCTGTTGCAAGTCTTGGCTTAAGGAGACTTCCTGTGGGTTGCCATGTCGCACGTCCGTTAGATCTTGATTTTACAGGTGAGGGTGGTTGCCAAAGGTGATAAGAAA
AGCAGCCAACAGGCTCCCTCTCACTTAAGAGAGTTCTAATTAATAACACTAAATTCTTCCTGAGAAATGACTCCTCTTGGTTTGGTTTGAAGTTTTTCAGTGAAGGAAAAGGCCTGAGATAGGAAGCA
GTGCCCTCGCTTCATGAGGTGGCACATCTTCGGTGGCCGTTGGCCTGGTCGAGCTTTGGTCAGCTGCGTGGGTGCCTGTCTCCTGTCTCCAGCGGCAGGGCATGGTTCTTGGCAGCCTGGTGTCCACA
CGGTGCATTCCTGTCCCCCTCGGCCCCAGGCTGGCTCAGCTCTCCAGTGCTGCGGCGCTGTCTTTGCAGCATTGCCATGTCACCGTAGCCCCCTTCACTCTTGGAAGTTTGGGGCTTCAAGGTTTATT
CTGGCAAGAACACCTCGGAGCCACTGCATTGTTTTGCCAAAAACTTACTGCAGATTAAGTAAAGAACTTAGATGCTAAATTACATCTAATTTTGTATGTTTTTTTAAATGTGTCTTTGATGCATACTT
TAGAAGCACACTGGCTCGCGGTTTCCATCCCTCTTGCCTTGGGACACTCTTGAGGCTGGCAGCCCTCCTGCAATGAGTTGCTCTCAGTTCCTTCTGTTTGGATTTTGCTCAACATCTCCAGTTTCTCT
GCTCTGAAAAATGGGGAAAACTGCTAAACATCCCAGAGATTTGCAATCTTCTAGCTCTCCAGGTGAGCAGAAAGACCAAATATCCAAATAAAAGCCTGAAAGCCATTGGTGATCCAGGGGCACCTTCT
CTTCAGCTTGACTGGGCGTCTTCCGCTGCATAACACTCAAGGTGTCTGCTCTAGTCATCCAGAAACCCACTCCCTTCTGAAGCCCCTCCTTGGGCCGGGTTGTATCAGGAGGATTCAACCCCGCTAAC
ATGTGGGGTGCCCTCTGTAGGCCTTCACACAGGGAAGGAAGCCCTACCCTTTCAACTCCTGTTGGAGTGAGAGTTTCCTGTTCTGATTCCACTGTGGCCAACCCAATAATTCTGTCCGAGGAGGGGTA
AGGGAATAGGAGGTGGGGAGCAAAGAGGGCAGCCTGACTAGATGCCCCTGCTGAATCTGGTACTTTCTGCACAGCCTTGAGTGATTGGAGTCCCCTAATGACTAATAAACTTGAACATGTAACACACA
CACACACACACACACACACCATTTTAGGAAGTGGTTCTCCTACTGGAAAATATGCTACAGAATGAAAGTTTGTAATTGAAAGAAAAAGAATGTATTCATCTGCTTCTTGGGTTTAAGCACACACCTGA
AGGGGAGATATTGGGGGACACGGTGGCCACTCGCGGTCTGTGTCATGACACTTCCCATTCACATCATTGGCCTGCGTTGCTGGGGCTTTGAACCACCACCCCGTACTTTGTTTTGCCTGTAGAGTGTT
GTAAAATATTTTGGATGTGAATGTCCTTGCAGGCCGGTTAGTCTCCAGTTTCCACAGAGACCACCTACCCACCACCTTCCCAGGTCACCTGCCTGGTCCCTGAAAGAAAGCATTTGTGTGGGCAATCC
CAACATGAAATGTAGACAGCGTGAATACGGACAGGAGGTGATGCCATATTCACAGTGGGGGATGGAGGGCCCCCACCCCTGCTTCACAGAATAATGGGAAGTGACTCTAGTCTTTGTAAGCAATTTTC
ATTCTCATTAGGAAGTTAAATGTAGATTCACAGATACATTTACTTTCAGAATCCTCAAGAGGATTTCAAATGCTAACTTTTAGTTTCTTGGGATTGATCAAGGCAAGAGAAGTGGCTTTAACCATGCC
AGCCAGAATGAAGCATCATGGGTCCTGATGGTTTCCCGTTTTCATGGTAACAAATTCGCACAGAGGTTTTGCTTTATGCTGTAGAATACCGACTTTCATGATGACAACTTGGTTTATGCATGAATATT
GCAGTATTTCCATATAGCAAAATAACATTTCTACCCAGGATAATAGTCACAGTTTTCCAGGGAGGGAATGATATAATTTTCATGACAATGTCATGTGATGATAGAATTTCTCCATTGATGAATCTCTA
GTATGTGTGTATACTTTATTTACCCATACGTATATTTTATGACCATGAGCTAAGTTGTTATTTCTTTCATTCATATCCCTGCTGAAATATTGGTACTAGCAACTTAAAGTTGGCAAGTCTCATCTTCA
GTAATACGGATGCCATGGGAGTGGCCAGGCCAGATTGAAGGTGAATATGGAGCAGTAGCAGAAGCCTCATTCCAGAACCCATCTGGCCAGAGAAGCAGCAGCATCCTGGGGGATGGCCGTGCATGGGG
TGTACACTCGCTATAGGCATAGGCCCGGCATGGCTGTCGCTGGACGCCAGCTGTGCACACCCAGCCACACCTGCTGCACGCCGCGTTAGTGTGCGGCTCCGGGCCTGAGCATTCGCAAAGCTCGCTTC
TCCAGGGAGCCTCCTCTTGGCTTTGGAAAAGAGCCCAGGGACTTAACGTGCTGCCTGTTGTACTCTGTCCCCTCATGACTTTTTAGACACAGGGACTAGGACATCGACCACCCTCTGCCCCTCCTGCA
GTCAGAACCCGAGTAGTGCAAGAACGGCCACCCGGTTTTGCCAGCGTTCAGCGTCTGCCCATGGACCCATAAGGCACATTAGCGTTGGGGGTCTCTTTTCAGCAGCCTCACAGACATTCCCGTCCTTT
CTGGTTGGTGTTGACTGTGTTTCAGCATCACTCTACCCTCCCATGTCCTTAGCATTGCTGTGCGTGTTTCCAGGCACTTAGGACACCCTTCCCCACGTTGCCATCTTACTGACAGTTCAAATGACTCT
CCTTTTTTGTTCGTTAGTAACAATCTTCATTTGACACCTTAATACATTTCTGACTGTTCTTAAAACAGTGGGGATGCCTATATTTTCCTTGAGTTTTTGTGACTGACTTTGGCTATATATACCTTTCT
GGGGTTTTGTTTGTTTTTTATTTTTATTTTGATTACCGAGGGTATTTGGGGTGGGGTTGTTTTTTGAGATGTGTAATTCTTTTATGGAGTTTTTAAAAAGAATTTTCATATTGTTTTTCTAACATGGC
TTCATTAAACGTTTAAGTATTTTAAAAATATGTAATATTTGGACCAGATGTTGTGAATAATAGTAGAGATAAAGCTATTTTATTCTGTATTTTTAAAACTGTTCCGTACAAATAAAAGCTCTCCTGGA
CACA

hide sequence


Protein RefSeqs	NP_005107	(Get FASTA)	NCBI Sequence Viewer
	NP_976072	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAC78806	(Get FASTA)	NCBI Sequence Viewer
	AAD11783	(Get FASTA)	NCBI Sequence Viewer
	AAF80493	(Get FASTA)	NCBI Sequence Viewer
	AAH13112	(Get FASTA)	NCBI Sequence Viewer
	AAQ79775	(Get FASTA)	NCBI Sequence Viewer
	AAY26157	(Get FASTA)	NCBI Sequence Viewer
	ABK34450	(Get FASTA)	NCBI Sequence Viewer
	AEE61185	(Get FASTA)	NCBI Sequence Viewer
	BAA13244	(Get FASTA)	NCBI Sequence Viewer
	BAG59003	(Get FASTA)	NCBI Sequence Viewer
	BAG59732	(Get FASTA)	NCBI Sequence Viewer
	CAB58120	(Get FASTA)	NCBI Sequence Viewer
	CAC83100	(Get FASTA)	NCBI Sequence Viewer
	EAX10438	(Get FASTA)	NCBI Sequence Viewer
	EAX10439	(Get FASTA)	NCBI Sequence Viewer
	EAX10440	(Get FASTA)	NCBI Sequence Viewer
	EAX10441	(Get FASTA)	NCBI Sequence Viewer
	EAX10442	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000344322
	ENSP00000344322.1
	ENSP00000368637
	ENSP00000368637.1
GenBank Protein	Q9UGH3	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:

NP_005107 ⟸ NM_005116

- UniProtKB:

Q9UNU1 (UniProtKB/Swiss-Prot), Q96D54 (UniProtKB/Swiss-Prot), Q92512 (UniProtKB/Swiss-Prot), Q8WWR4 (UniProtKB/Swiss-Prot), B4DJZ1 (UniProtKB/Swiss-Prot), Q9UP85 (UniProtKB/Swiss-Prot), Q9UGH3 (UniProtKB/Swiss-Prot), A0A140VK48 (UniProtKB/TrEMBL), A0MSJ5 (UniProtKB/TrEMBL)

- Sequence:

show sequence

MMGIGKNTTSKSMEAGSSTEGKYEDEAKHPAFFTLPVVINGGATSSGEQDNEDTELMAIYTTENGIAEKSSLAETLDSTGSLDPQRSDMIYTIEDVPPWYLCIFLGLQHYLTCFSGTIAVPFLLADAM
CVGYDQWATSQLIGTIFFCVGITTLLQTTFGCRLPLFQASAFAFLAPARAILSLDKWKCNTTDVSVANGTAELLHTEHIWYPRIREIQGAIIMSSLIEVVIGLLGLPGALLKYIGPLTITPTVALIGL
SGFQAAGERAGKHWGIAMLTIFLVLLFSQYARNVKFPLPIYKSKKGWTAYKLQLFKMFPIILAILVSWLLCFIFTVTDVFPPDSTKYGFYARTDARQGVLLVAPWFKVPYPFQWGLPTVSAAGVIGML
SAVVASIIESIGDYYACARLSCAPPPPIHAINRGIFVEGLSCVLDGIFGTGNGSTSSSPNIGVLGITKVGSRRVIQCGAALMLALGMIGKFSALFASLPDPVLGALFCTLFGMITAVGLSNLQFIDLN
SSRNLFVLGFSIFFGLVLPSYLRQNPLVTGITGIDQVLNVLLTTAMFVGGCVAFILDNTIPGTPEERGIRKWKKGVGKGNKSLDGMESYNLPFGMNIIKKYRCFSYLPISPTFVGYTWKGLRKSDNSR
SSDEDSQATG

hide sequence

RefSeq Acc Id:

NP_976072 ⟸ NM_203327

- UniProtKB:

- Sequence:

show sequence

MMGIGKNTTSKSMEAGSSTEGKYEDEAKHPAFFTLPVVINGGATSSGEQDNEDTELMAIYTTEN
GIAEKSSLAETLDSTGSLDPQRSDMIYTIEDVPPWYLCIFLGLQHYLTCFSGTIAVPFLLADAMCVGYDQWATSQLIGTIFFCVGITTLLQTTFGCRLPLFQASAFAFLAPARAILSLDKWKCNTTDV
SVANGTAELLHTEHIWYPRIREIQGAIIMSSLIEVVIGLLGLPGALLKYIGPLTITPTVALIGLSGFQAAGERAGKHWGIAMLTIFLVLLFSQYARNVKFPLPIYKSKKGWTAYKLQLFKMFPIILAI
LVSWLLCFIFTVTDVFPPDSTKYGFYARTDARQGVLLVAPWFKVPYPFQWGLPTVSAAGVIGMLSAVVASIIESIGDYYACARLSCAPPPPIHAINRGIFVEGLSCVLDGIFGTGNGSTSSSPNIGVL
GITKVGSRRVIQCGAALMLALGMIGKFSALFASLPDPVLGALFCTLFGMITAVGLSNLQFIDLNSSRNLFVLGFSIFFGLVLPSYLRQNPLVTGITGIDQVLNVLLTTAMFVGGCVAFILDNTIPGTP
EERGIRKWKKGVGKGNKSLDGMESYNLPFGMNIIKKYRCFSYLPISPTFVGYTWKGLRKSDNSRSSDEDSQATG

hide sequence

Ensembl Acc Id:

ENSP00000396364 ⟸ ENST00000423430

Ensembl Acc Id:

ENSP00000344322 ⟸ ENST00000338244

Ensembl Acc Id:

ENSP00000368637 ⟸ ENST00000379333

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9UGH3-F1-model_v2	AlphaFold	Q9UGH3	1-650	view protein structure

RGD ID:

6799081

Promoter ID:

HG_KWN:38484

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, HeLa_S3, K562, Lymphoblastoid, NB4

Transcripts:

NM_005116, UC002WLJ.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	20	4,929,831 - 4,930,331 (-)	MPROMDB

RGD ID:

13206289

Promoter ID:

EPDNEW_H26727

Type:

multiple initiation site

Name:

SLC23A2_3

Description:

solute carrier family 23 member 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26728 EPDNEW_H26729

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	4,949,963 - 4,950,023	EPDNEW

RGD ID:

13206295

Promoter ID:

EPDNEW_H26728

Type:

initiation region

Name:

SLC23A2_1

Description:

solute carrier family 23 member 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26727 EPDNEW_H26729

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	5,001,502 - 5,001,562	EPDNEW

RGD ID:

13206297

Promoter ID:

EPDNEW_H26729

Type:

multiple initiation site

Name:

SLC23A2_2

Description:

solute carrier family 23 member 2

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H26727 EPDNEW_H26728

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	20	5,010,313 - 5,010,373	EPDNEW

Database	Acc Id	Source(s)
COSMIC	SLC23A2	COSMIC
Ensembl Genes	ENSG00000089057	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000338244	ENTREZGENE
	ENST00000338244.6	UniProtKB/Swiss-Prot
	ENST00000379333	ENTREZGENE
	ENST00000379333.5	UniProtKB/Swiss-Prot
GTEx	ENSG00000089057	GTEx
HGNC ID	HGNC:10973	ENTREZGENE
Human Proteome Map	SLC23A2	Human Proteome Map
InterPro	Xan_ur_permease	UniProtKB/Swiss-Prot
	Xant/urac/vitC	UniProtKB/Swiss-Prot
KEGG Report	hsa:9962	UniProtKB/Swiss-Prot
NCBI Gene	9962	ENTREZGENE
OMIM	603791	OMIM
PANTHER	XANTHINE-URACIL / VITAMIN C PERMEASE FAMILY MEMBER	UniProtKB/Swiss-Prot
Pfam	Xan_ur_permease	UniProtKB/Swiss-Prot
PharmGKB	PA35849	PharmGKB
PROSITE	XANTH_URACIL_PERMASE	UniProtKB/Swiss-Prot
UniProt	A0A140VK48	ENTREZGENE, UniProtKB/TrEMBL
	A0MSJ5	ENTREZGENE, UniProtKB/TrEMBL
	B4DJZ1	ENTREZGENE
	H0Y544_HUMAN	UniProtKB/TrEMBL
	Q4ZGM1_HUMAN	UniProtKB/TrEMBL
	Q8WWR4	ENTREZGENE
	Q92512	ENTREZGENE
	Q96D54	ENTREZGENE
	Q9UGH3	ENTREZGENE
	Q9UNU1	ENTREZGENE
	Q9UP85	ENTREZGENE
	S23A2_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	B4DJZ1	UniProtKB/Swiss-Prot
	Q8WWR4	UniProtKB/Swiss-Prot
	Q92512	UniProtKB/Swiss-Prot
	Q96D54	UniProtKB/Swiss-Prot
	Q9UNU1	UniProtKB/Swiss-Prot
	Q9UP85	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2016-03-08	SLC23A2	solute carrier family 23 member 2	SLC23A2	solute carrier family 23 (ascorbic acid transporter), member 2	Symbol and/or name change	5135510	APPROVED
2013-07-23	SLC23A2	solute carrier family 23 (ascorbic acid transporter), member 2	SLC23A2	solute carrier family 23 (nucleobase transporters), member 2	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD

Send us a Message

Imported Disease Annotations - ClinVar

Imported Disease Annotations - CTD